march 31 (sun) pm / d Ô ¢ Ô£ · march 31 pm 419 2 } increased circulating blood volume as a...

March

31

PM

417

March 31 (Sun) PM / 3月31日（日）午後

Special Lecture 11 特別講演 11March 31 (Sun) 15：10－15：55503, 5F, Conference Center

Chairperson：Issei Komuro（Professor, Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo,Tokyo）

Transcriptional Control of Cardiac Regeneration and Reprogramming

Eric N. Olson（UT Southwestern Medical Center, USA）

Special Lecture 12 特別講演 12March 31 (Sun) 15：55－16：40503, 5F, Conference Center

Chairperson：Tetsuji Miura（Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Sapporo）

Heart Failure: Two Inflammatory Tales

Joseph A. Hill（UT Southwestern Medical Center, USA）

Invited Lecture 12 招聘講演 12March 31 (Sun) 13：30－14：00502, 5F, Conference Center

Chairperson：Yasuki Kihara（Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical & HealthSciences, Hiroshima）

Prevention of Drug-induced Torsade de Pointes

Richard Kovacs（American College of Cardiology, USA）


Chairperson：Hiroshi Itoh（Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Okayama）

The Current and Future Impact of TAVR on Cardiovascular Medicine - My Crystal Ball for the Next

Decade

Eberhard Grube（University Hospital Bonn, Germany）


Chairperson：Yoshihiko Saito（Department of Cardiovascular Medicine, Nara Medical University, Kashihara）

25 Years of Cardiac Tissue Engineering -A Translational Journey

Thomas Eschenhagen（University Medical Center Hamburg-Eppendorf, Germany）


Chairperson：Akihiko Nogami（Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba）

Stroke Prevention in Patients with Atrial Fibrillation: Lessons from the Clinical Trials and Big Data

Analysis

Shih-Ann Chen（Taipei Veterans General Hospital, Taiwan）

March

31

PM

418


Chairperson：Takanori Ikeda（Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo）

Catheter Mapping/Ablation of Brugada Syndrome: Japanese Experience

Hiroshi Nakagawa（Heart Rhythm Institute, University of Oklahoma Health Sciences Center, USA）


Chairperson：Yasunobu Hirata（Tokyo Teishin Hospital, Tokyo）

Aortic Aneurysm and Dissection: The Translational Journey fromMarfan to Sartan and Back

Bart L. Loeys（University of Antwerp, Belgium/Antwerp University Hospital, Belgium）

Plenary Session 13 (SHD)

March 31 (Sun) 13：30－15：00301, 3F, Conference Center

Comprehensive Management for Critical State of Acute Myocardial Infarction

Chairpersons：Antonio Colombo（EMO GVM Centro Cuore Columbus, Italy/San Raffaele Hospital, Italy）Morimasa Takayama（Department of Cardiology, Sakakibara Heart Institute, Fuchu）

State-of-the-Art：1．My View Regarding Complex Coronary InterventionsAntonio Colombo（EMO and GVM Laboratories, Lugo and Milan, Italy）

2．Temporal Trends in Emergency Care and Outcomes of Geriatric Patients with Acute MyocardialInfarction -Report from the Miyagi AMI Registry-

Jun Takahashi（Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai）3．Impact of PCI for Left Main Culprit Lesion on In-Hospital Mortality: Report from the Japan AcuteMyocardial Infarction Registry (JAMIR)

Kensaku Nishihira（National Cerebral and Cardiovascular Center, Suita）4．Impact of Extracorporeal Membrane Oxygenation (ECMO) and Intra-Aortic Balloon Pump (IABP) forCardiogenic Shock after Cardiac Arrest

Norihiro Kuroki（Tokyo CCU Network, Scientific Committee, Tokyo/Department of Cardiology, Tokyo Metropolitan BokutohHospital, Tokyo）

5．JCS Board-certified Cardiologists Positively Impact on the Prognosis of Acute Myocardial Infarctionwith Cardiogenic Shock: The JROAD/JROAD-DPC study

Tetsuya Matoba（Department of Cardiovascular Medicine, Kyushu University, Fukuoka）6．Early Resuscitation of Cardiogenic Shock by Cooperation of Emergency Medical System andCardiovascular Intensive Care Unit

Hiroshi Imamura（Department of Emergency and Critical Care Medicine, Shinshu University, Matsumoto）

Plenary Session 14 (HF/CM)


How DoWe Manage Adults with Fontan Circulation?

Chairpersons：Peter Zartner（German Pediatric Heart Center, Germany）Hideo Ohuchi（Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Suita）

State-of-the-Art：1．How DoWe Manage Adults with Fontan Circulation? (State of the Art)Peter Zartner（German Paediatric Heart Centre, Sankt Augustin, Germany）

March

31

PM

419

2．Increased Circulating Blood Volume as a Compensatory Adaptation in Adult Fontan Patients withHigh Cardiac Output Failure

Hideo Ohuchi（Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Suita）3．Unique Features of Hepatic Disease in Adults with Fontan Circulation: A Comparison with CongenitalHeart Disease Patients after Two-ventricular Repair

Norihisa Toh（Department of Cardiology, Okayama University, Okayama）4．Combination Therapy with Warfarin and Aspirin is Effective for Thromboembolic Prophylaxis butIncreases Bleeding in Patients with Fontan Operation

Shintaro Umemoto（Department of Cardiovascular Medicine, Kyushu University School of Medicine, Fukuoka）5．The Pathologic Changes of Placenta in Pregnancy with Fontan CirculationTae Konishi（Department of Perinatology and Gynecology, National Cerebral and Cardiovascular Center, Suita）

6．Long Time Follow-up for Fontan Patients; Should We Choose Transplant or Palliative Care?Takayoshi Ueno（Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita）

シンポジウム 243月 31日（日） 15：10－16：40国立大ホール 2階超高齢化・医療費膨張時代における循環器医療提供体制と医療政策のあり方座長：後藤葉一（公立八鹿病院）代田浩之（順天堂大学循環器内科）

1．Establishment of Indicators and Outcome Prediction Model of Acute Cardiovascular Diseases toImprove Cardiovascular Medical Service System

坂田泰史（大阪大学循環器内科学）2．Current Status and Future Shape of Cardiovascular Care in Japan: Importance of Exercise andNutrition Intervention in Post-discharge Disease Management

後藤葉一（公立八鹿病院）3．Clinical Pathway and Multidisciplinary Collaboration by Hospital and Home Care TeamworkFacilitates Integrated Management and Communication for Cardiovascular Disease Treatment

渡辺德（長野県厚生連北信総合病院循環器科）4．Medical and Nursing Collaboration by Using Scoring Systems for Preventing Readmission in ElderlyPatients with Decompensated Heart Failure

中根英策（北野病院）5．Let Your Life Glow, Cardiologists!邉見公雄（特定非営利活動法人地域医療・介護研究会JAPAN）

6．Overview of Healthcare Policy in the Era of Super-aging迫井正深（厚生労働省大臣官房審議官）

Symposium 25

March 31 (Sun) 15：10－16：40Main Hall, 1F, Conference Center

Medical Innovation by Big Data Analysis and Artificial Intelligence

Chairpersons：Khung Keong Yeo（National Heart Centre Singapore, Singapore）Satoshi Yasuda（National Cerebral and Cardiovascular Center, Suita）

Keynote Lecture：1．The Role of AI in Cardiology: Pitfalls and OpportunitiesKhung Keong Yeo（National Heart Centre Singapore, Singapore）

2．A Noble Method of Heart Failure Evaluation Based on Walkability Analysis with Artificial IntelligenceHirotada Masuda（Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita）

3．Transcultural Lessons in Managements and Outcomes for Hospitalized Heart Failure; Insight fromNational Claim Data across Asian and Western Countries

Toshiyuki Nagai（Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo）

March

31

PM

420

4．Real-world Application of Big Data in Cardiovascular Science -Report from the Tohoku University BigData Medicine Center-

Kotaro Nochioka（Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, and TohokuUniversity Big Data Medicine Center, Sendai）

5．AI Based Registry Formation and Its Application for Prediction Models -The Experience ofIntroduction of Natural Language Processing in Electric Medical Records in National Cerebral and

Cardiovascular Center-

Kunihiro Nishimura（National Cerebral and Cardiovascular Center, Department of Preventive Medicine, Suita）

シンポジウム 26 (VD/RF)3月 31日（日） 13：30－15：00アネックスホール 2階「F205＋F206」レジストリーによる脳卒中と循環器疾患の診療実態座長：小川久雄（国立循環器病研究センター）飯原弘二（九州大学脳神経外科）

1．Multimorbidity in Patients with Cardiovascular Disease; Report from the Japanese Registry of AllCardiac and Vascular Diseases (JROAD)

安田聡（国立循環器病研究センター）2．The Impact of Cardiac Comorbidity on Outcome of Carotid Revascularization: J-ASPECT Study飯原弘二（九州大学大学院医学研究院脳神経外科）

3．Complementary Relationship between Atrial Fibrillation and Stroke Registries: Experience from theORBIT-AF Registry and the GWTG-Stroke Registry in the US

猪原拓（Duke Clinical Research Institute, Duke University Medical Center, USA）4．Impact of Cerebrovascular Comorbidity on Prognosis in Japanese Patients Undergoing PCI: 1-yearData from Japanese Multicenter Registry (KICS)

辻田賢一（熊本大学循環器内科学）5．Prognostic Impacts of Stroke and Antithrombotic Therapies in a Large-scale Cohort Study -Real-world Data from the CHART-2 Study-

白戸崇（東北大学循環器内科学）

シンポジウム 273月 31日（日） 15：10－16：40アネックスホール 2階「F205＋F206」新専門医制度における若手循環器医師の育成と問題点座長：木原康樹（広島大学循環器内科学）宮崎俊一（近畿大学循環器内科）

1．Unmet Needs of Japanese Early-career Cardiologist in Their Cardiovascular Training Programs河野隆志（慶應義塾大学呼吸循環器内科）

2．Flexible Training Program for Double Board Certifications with Cardiology and General Medicine哲翁-塚田弥生（日本医科大学武蔵小杉病院救急・総合診療センター総合診療科）

3．General Cardiologist in Super-aged Japanese Society: Essential Relation with Internal MedicineTraining

梶波康二（金沢医科大学循環器内科学）4．New Training System for Board Certified Cardiologist in Training of Young Physicians in Japan岩永善高（近畿大学循環器内科学）

5．Issues of Board System of The Japanese Association of Cardiovascular Intervention andTherapeutics

上妻謙（帝京大学循環器内科）

March

31

PM

421

Special Session 20 会長特別企画 20March 31 (Sun) 13：30－15：00Main Hall, 1F, Conference Center

Proposal of Novel Clinical Trials Lead to Breakthrough

Chairpersons：Su Ping Carolyn Lam（National Heart Centre Singapore, Singapore）Shun Kohsaka（Department of Cardiology, Keio University School of Medicine, Tokyo）

Keynote Lecture：1．FromMechanisms to Novel Clinical Trials in Heart Failure with Preserved Ejection FractionSu Ping Carolyn Lam（National Heart Centre Singapore, Singapore）

2．Development of the Trans-omics Cohort for Cardiovascular Patients in Japan: A Challenge of theCHART-2 Study

Yasuhiko Sakata（Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai）3．The Role and Future Direction of Registry Studies in Atrial FibrillationMasaharu Akao（Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto）

4．A Proposal for a New Concept of Clinical Research in Our HospitalHiroyuki Kiriyama（Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo）

Special Session 21 会長特別企画 21March 31 (Sun) 13：30－15：00503, 5F, Conference Center

Editor-in-Chief

Chairpersons：Fausto J. Pinto（University of Lisbon, Portugal）Toyoaki Murohara（Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya）

1．The JCI -Challenges in Scientific PublishingGordon F. Tomaselli（Albert Einstein College of Medicine, USA）

2．Circulation: Your Partner in the Fight against Cardiovascular DiseaseJoseph A. Hill（UT Southwestern Medical Center, USA）

3．Douglas L. Mann（Cardiovascular Division, Washington University School of Medicine, USA）4．The Future of Circulation: Cardiovascular Imaging: Expanding Our Reach and Enhancing Our ValueRobert J. Gropler（Washington University School of Medicine, USA）

5．Circulation ReportsMasataka Sata（Department of Cardiovascular Medicine, Tokushima University Graduate School, Tokushima）

Special Session 22 会長特別企画 223月 31日（日） 13：30－15：00アネックスホール 2階「F201＋F202」学会と患者会の新しい関係～繋がり共に歩む総合司会：波多野将（東京大学重症心不全治療開発講座）村上紀子（PAHの会理事長）

1．全国心臓病の子どもを守る会神永芳子（会長）斉藤幸枝（理事）

2．日本心臓ペースメーカー友の会井上美枝子（副会長）須磨幸蔵（名誉会長・東京女子医科大学名誉教授）

3．日本 ICDの会藤田竹思良（理事長）石川陽一（副理事長）市成浩太郎（監事/循環器内科医師）

4．PAHの会村上紀子（理事長）田村雄一（医学顧問・国際医療福祉大学三田病院）患者会から2名

March

31

PM

422

Special Session 23 会長特別企画 233月 31日（日） 15：10－16：40アネックスホール 2階「F201＋F202」Digital Medicine

座長：青沼和隆（筑波大学医学医療系循環器内科）夛田浩（福井大学病態制御医学講座循環器内科学）

1．Secondary Use of Clinical Data from Hospital Information Systems中山雅晴（東北大学医学情報学）

2．CLIDASⓇ, A Clinical Deep Data Accumulation System for Future Cardiology藤田英雄（自治医科大学さいたま医療センター循環器内科）

3．The Future of Arrhythmia Therapy Using Remote Monitoring荷見映理子（東京大学循環器内科）

4．The Role of Doctorepreneur in the New Era of Digital Health石見陽（メドピア株式会社）

ESC-JCS Joint Symposium (A)


Recent Advances in the Management of Atrial Fibrillation

Chairpersons：Jeroen J. Bax（Leiden University Medical Centre, The Netherlands）Takeshi Yamashita（The Cardiovascular Institute, Tokyo）

1．Asymptomatic Atrial Fibrillation: Detection, Clinical Significance and TreatmentBarbara Casadei（University of Oxford, UK）

2．Benefits of Anticoagulation with Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patientswith Atrial Fibrillation in Japan: Insights from the CHART-2 Study

Hiroaki Shimokawa（Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai）3．Treatment Strategies for Atrial Fibrillation with Heart FailureMichel Komajda（Department of Cardiology, Saint Joseph Hospital, France）

4．Rhythm and Rate Control Therapies for Management of Patients with Atrial FibrillationTakanori Ikeda（Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo）

ACC-JCS Joint Symposium (O)


Prediction and Prevention of Sudden Cardiac Death

Chairpersons：Richard Kovacs（American College of Cardiology, USA）Wataru Shimizu（Division of Cardiology, Nippon Medical School Department of Medicine, Tokyo）

1．Sudden Cardiac Death in AthletesRichard Kovacs（American College of Cardiology, USA）

2．Prevention of Sudden Cardiac Death in Hypertrophic CardiomyopathyHitoshi Takano（Department of Cardiovascular Medicine, Nippon Medical School, Tokyo）

3．Genetic Background in Patients with Idiopathic Ventricular Fibrillation: Known Gene Screening fromWhole Exome Analysis Data

Takeshi Aiba（National Cerebral and Cardiovascular Center, Suita）

March

31

PM

423

ラウンドテーブルディスカッション 73月 31日（日） 13：30－14：30会議センター 5階「501」医療の地域格差と地域連携座長：伊藤正明（三重大学循環器・腎臓内科学）久木山清貴（山梨大学第二内科）

1．Approaches for Improvement of Care of Acute Coronary Syndrome in Iwate Prefecture; From a GrandDesign to Priority Policies

森野禎浩（岩手医科大学内科学講座循環器内科分野）2．Multi-disciplinary and Integrated Community Care Collaboration Support People with CardiovascularDisease, Living in Rural Aged Area with Accelerating Population Decrease

渡辺徳（長野県厚生連北信総合病院循環器科）3．The Current Medical Care Situation in Yamagata Prefecture渡辺昌文（山形大学内科学第一講座（循環・呼吸・腎臓内科学））

ラウンドテーブルディスカッション 83月 31日（日） 14：35－15：35アネックスホール 2階「F203＋F204」低侵襲循環器治療の今後の展開：ハートチームをいかに発展させるか座長：泉知里（国立循環器病研究センター心臓血管内科）坂口太一（兵庫医科大学心臓血管外科）

1．Totally Endoscopic Mitral Valve Repair for the Best Heart Team Practice田端実（東京ベイ・浦安市川医療センター）

2．Efficacy and Optimal Patient Selection of MitraClip for Severe Mitral Regurgitation in Japanese Real-world Clinical Practice

久保俊介（倉敷中央病院循環器内科）3．Hybrid Coronary Revascularization and MICS CAB中村喜次（千葉西総合病院心臓血管外科）

ラウンドテーブルディスカッション 9 (HF/CM)3月 31日（日） 15：40－16：40アネックスホール 2階「F203＋F204」急性心不全の初期対応の日本の現状と課題座長：佐藤直樹（日本医科大学武蔵小杉病院循環器科・集中治療室）菊地研（獨協医科大学心臓・血管内科）

1．Current Status and Issues of EMS Paramedics Treatment to Acute Heart Failure田中秀治（国士舘大学大学院救急システム研究科）

2．The Importance of Prehospital Care in Acute Heart Failure石原嗣郎（日本医科大学武蔵小杉病院循環器内科）

3．Prehospital Evaluation and Management in Patients with Acute Heart Failure白石泰之（慶應義塾大学循環器内科学）

4．Current Situation and Problems of First Responders after Patients with Acute Decompensated HeartFailure Arrive at the Hospital

田原良雄（国立循環器病研究センター心臓血管内科）

March

31

PM

424

トピック 213月 31日（日） 13：30－14：30会議センター 3階「303」AIが切り拓く未来の医療座長：永井良三（自治医科大学）西村邦宏（国立循環器病研究センター予防医学疫学情報部）

1．Development of the Integrated Medical System Using Artificial Intelligence: Towards the Realizationof Precision Medicine

浜本隆二（国立がん研究センター研究所がん分子修飾制御学分野）2．Future of AI and Its Impact to Medicine松尾豊（東京大学工学系研究科）

トピック 22 (O)3月 31日（日） 14：35－15：35会議センター 3階「303」費用対効果から循環器治療を再考する座長：田倉智之（東京大学医療経済政策学講座）五十嵐中（東京大学薬学系研究科医薬政策学寄付講座）

1．Cost-effectiveness Analysis of Cardiovascular Disease Treatment in Japan小寺聡（東京大学循環器内科）

2．Cost-effectiveness Evaluation and Cardiovascular Guidelines坂巻弘之（東京理科大学経営学部）

Topic 23 (HF/CM)


Athlete’s Heart -Current Knowledge and Future Perspectives

Chairpersons：Shigeru Makita（Department of Cardiac Rehabilitation, Saitama Medical University, International Medical Center, Saitama）Hirokazu Shiraishi（Department of Cardiovascular Medicine, Rehabilitation Unit, Kyoto Prefectural University of Medicine,Kyoto）

1．Cardiac Structure in Elite Basketball PlayersShunichi Homma（Department of Medicine/Division of Cardiology at Columbia University Medical Center, USA）

2．Association between Myocardial Triglyceride Content and Cardiac Function in Healthy Subjects,Endurance Athletes, and Patients with Hypertrophic Cardiomyopathy

Kazunori Shimada（Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo）3．Electrical and Structural Adaptation of Athlete’s Heart in Japanese AdolescentsYoshitaka Iso（Showa University Research Institute for Sport and Exercise Sciences, Yokohama）

コントロバーシー 6 (SHD)3月 31日（日） 13：30－14：30アネックスホール 2階「F203＋F204」どうする三尖弁逆流の治療方針：内科治療優先？早期外科手術？座長：竹村博文（金沢大学先進総合外科）渡辺弘之（東京ベイ・浦安市川医療センターハートセンター）

1．Early Surgery for Asymptomatic Severe Tricuspid Regurgitation; Is it Ready Now?泉知里（国立循環器病研究センター心臓血管内科）

2．Should We Perform Early Surgery in Patients with Isolated Tricuspid Regurgitation? “Probably Yes.”阿部幸雄（大阪市立総合医療センター循環器内科）

March

31

PM

425

ミート・ザ・エキスパート 11 (HF/CM)3月 31日（日） 14：35－15：35会議センター 5階「501」心筋症の新しい話題座長：桑原宏一郎（信州大学循環器内科学教室）久保亨（高知大学老年病・循環器内科学）

1．Catecholamine Toxicity and Takotsubo Cardiomyopathy; The Alteration ofΒ-Adrenoceptor in LeftVentricle of Acute Phase Takotsubo Cardiomyopathy

尾上健児（奈良県立医科大学循環器内科）2．Hot Topics in Peripartum Cardiomyopathy: Genetics and Disease-specific Treatment神谷千津子（国立循環器病研究センター周産期・婦人科部）

3．Application of Whole Exome Sequencing Data for Detection of Large Genomic Rearrangements inCardiomyopathy

朝野仁裕（大阪大学循環器内科学）

ミート・ザ・エキスパート 123月 31日（日） 15：40－16：40会議センター 5階「501」ナショナルデータベースの研究利用座長：福原俊一（京都大学/福島県立医科大学）康永秀生（東京大学公共健康医学専攻臨床疫学・経済学分野）

1．Conducting Database Research on Cardiovascular Diseases Using the NDB福田治久（九州大学医療経営学）

2．Application of the Diagnosis Procedure Combination (DPC) Database to Cardiovascular Research inJapan

磯貝俊明（東京都立多摩総合医療センター循環器内科/Department of Clinical Epidemiology and Health Economics, Schoolof Public Health, The University of Tokyo, Tokyo）

March

31

PM

426

Featured Research Session 14 (CAD)

March 31 (Sun) 15：10－16：40414＋415, 4F, Conference CenterCoronary Artery Diseases (Clinical) 3

Chairpersons：Ik-Kyung Jang（Massachusetts General Hospital, Harvard Medical School, USA）Tetsuya Amano（Department of Cardiology Aichi Medical University, Nagakute）

Keynote Lecture：FRS14-1 Cardiac OCT: 20 Years -From Bench to Plaque Erosion

Ik-Kyung Jang（Massachusetts General Hospital, Harvard Medical School, USA）FRS14-2 Guideline Adherence and Long-term Clinical Outcomes in Patients with Acute Myocardial

Infarction: J-MINUET Substudy

Hideki Wada（Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Izuonokuni）FRS14-3 Primary Percutaneous Coronary Intervention and Clinical Outcome in Elderly Patients with

Acute Myocardial Infarction: From JROAD-DPC Registry

Shiro Uemura（Cardiovascular Medicine, Kawasaki Medical School, Kurashiki）FRS14-4 Comparison of 5-year Outcomes after CABG and PCI in Very Old Patients with Severe

Coronary Artery Disease

Hiroyuki Hara（Japan Red Cross Wakayama Medical Center, Wakayama）FRS14-5 Nocturnal Hypoxemic Burden in Patients with Vasospastic Angina

Yusuke Nakagawa（Department of Cardiology, Kawanishi Hospital, Kawanishi）

Featured Research Session 15 (VD/RF)

March 31 (Sun) 13：30－15：00416＋417, 4F, Conference CenterAortic Diseases, Resusciation (Clinical)

Chairpersons：Chi Young Shim（Severance Cardiovascular Hospital, Yonsei University College of Medicine, Korea）Taishiro Chikamori（Department of Cardiology, Tokyo Medical University, Tokyo）

Keynote Lecture：FRS15-1 Role of Echocardiography in Acute Cardiac Condition

Chi Young Shim（Severance Cardiovascular Hospital, Yonsei University College of Medicine, Korea）FRS15-2 In-hospital Outcomes of Surgical versus Endovascular Repair for Ruptured Abdominal Aortic

Aneurysm

Tetsuo Yamaguchi（Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo）FRS15-3 The Impact of Hypertension on the Aortic Artery Disease-related Mortality: 3.8 Years

Nationwide Community-Based Prospective Cohort Study

Yoichiro Otaki（Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine,Yamagata）

FRS15-4 Construction and Validation of a New Termination-of-Resuscitation Rule for Out-of-Hospital

Cardiac Arrest

Katsutaka Hashiba（Department of Cardiology, Saiseikai Yokohamashi Nanbu Hospital, Yokohama）FRS15-5 The Importance of Time to Extracorporeal Cardiopulmonary Resuscitation in Patients with

Out-of-Hospital Cardiac Arrest Due to Acute Coronary Syndrome

Shoji Kawakami（Department of Cardiology, Aso Iizuka Hospital, Fukuoka）

Featured Research Session 16 (CAD)

March 31 (Sun) 15：10－16：40416＋417, 4F, Conference CenterThromboembolism, Anti-thrombotic Therapy (Clinical) 2

Chairpersons：Fausto J. Pinto（Faculty of Medicine, Lisbon University, Portugal）Teruo Inoue（Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu）

Keynote Lecture：FRS16-1 New Approaches in the Management of Anti-coagulation in Atrial Fibrillation

Fausto J. Pinto（Faculty of Medicine, Lisbon University, Portugal）

March

31

PM

427

FRS16-2 Influence of Baseline Anemia on Long-term Clinical Outcomes in Patients with Venous

Thromboembolism: From the COMMAND VTE Registry

Yugo Yamashita（Graduate School of Medicine, Kyoto University, Kyoto）FRS16-3 Risk Factors for Recurrence in Patients with First Unprovoked Venous Thromboembolism:

From the COMMAND VTE Registry

Hideo Amano（Department of Cardiology, Kurashiki Central Hospital, Kurashiki）FRS16-4 Risk Factors for Post-thrombotic Syndrome in Patients with Deep Vein Thrombosis: From the

COMMAND VTE Registry

Yuji Nishimoto（Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki）FRS16-5 Impact of Post-Discharge Bleeding on Long-TermMortality in Percutaneous Coronary

Intervention Patients Taking an Oral Anticoagulant

Ruka Yoshida（Department of Cardiology, Nagoya University Hospital, Nagoya）

March

31

PM

428

Oral Presentation (English) 32 (CAD)

March 31 (Sun) 13：30－15：00411＋412, 4F, Conference CenterACS/AMI (Clinical/Diagnosis)

Chairpersons：Kazuhiko Nakazato（Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima）Jiro Aoki（Division of Cardiology, Mitsui Memorial Hospital, Tokyo）

OE32-1 Impact of Low Body Mass Index for Short-term and Mid-term Outcomes of Patients with Acute

Myocardial Infarction

Goro Yoshioka（Miyazaki Medical Association Hospital Cardiovascular Center, Miyazaki）OE32-2 Clinical Characteristics and Morphological Culprit Plaque Features in Patients with Acute

Coronary Syndrome

Akira Nagasawa（Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University GraduateSchool of Medicine, Kobe）

OE32-3 Index of Microcirculatory Resistance as a Predictor of Cardiac Outcomes in Patients with ST-

Elevation Myocardial Infarction Undergoing Primary Coronary Intervention

Takayuki Onishi（Department of Cardiology, Hiratsuka Kyosai Hospital, Hiratsuka）OE32-4 Erectile Dysfunction among Acute Coronary Syndrome Patients in Singapore: Prevalence, Risk

Factors, and Clinical Characteristics

Alex Yufei Xie（Duke-NUS Medical School, Singapore）OE32-5 Urinary Liver-type Fatty Acid-Binding Protein and N-Terminal Pro-B-Type Natriuretic Peptide

Predict Acute Kidney Injury in Patients with Acute Coronary Syndrome

Hiroyuki Naruse（Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University, Toyoake）OE32-6 Biphasic Occurence and Presentation of Left Ventricular Free Wall Rupture with Acute

Myocardial Infarction in Primary Percutaneous Coronary Intervention Era

Hirohide Matsuura（Miyazaki Medical Association Hospital Cardiovascular Center, Miyazaki）OE32-7 Computational Flow Simulation of Coronary Aneurysm in Patients with ST-segment Elevation


Yosuke Miyazaki（Department of Medicine and Clinical Science, Yamaguchi University, Ube）OE32-8 Impact of Right-ventricular Branch Slow-flow Phenomenon Post Percutaneous Coronary

Intervention for Acute Coronary Syndrome to Predict Future Prolonged Right-ventricular

Dysfunction

Kohshi Setoyama（The Second Department of Internal Medicine, University of Occupational and EnvironmentalHealth, Kitakyusyu）

OE32-9 Impacts of BMI Status on Long-term Outcomes of Patients with Acute Coronary Syndrome

Undergoing Percutaneous Coronary Intervention

Kotaro Mochida（The Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo）

Oral Presentation (English) 33 (CAD)

March 31 (Sun) 15：10－16：40411＋412, 4F, Conference CenterACS/AMI

Chairpersons：Shinichiro Yamada（Division of Cardiology, Kita-Harima Medical Center, Ono）Nobuhiko Maejima（Division of Cardiology, Yokohama City University Medical Center, Yokohama）

OE33-1 Long-term Outcomes after Culotte or T Stenting for Non-left Main Bifurcation Lesions

Compared between First- and Second-generation Drug-eluting Stents

Masanobu Ohya（Department of Cardiology, Kurashiki Central Hospital, Kurashiki）OE33-2 Impact of OCT in Evaluating Intra-procedural Stent Thrombosis

Hiroko Tsuchiya（Department of Cardiology, Saiseikai Maebashi Hospital, Maebashi）OE33-3 Prognostic Implications of Time between Balloon to Peak Creatinine Kinase-MB in Patients

with Acute Myocardial Infarction Undergoing Primary PCI

Issei Ishida（Department of Cardiology, Tokyo Women’s Medical University, Tokyo）OE33-4 The Roles of East Asians Mitochondrial Aldehyde Dehydrogenase 2 Genotypes in Nitrate

Tolerance and Endothelial Dysfunction

Yuji Mizuno（Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute,Kumamoto）

March

31

PM

429

OE33-5 Differences in the Usefulness of Aggressive Lipid-lowering Therapy among Single-vessel and

Multi-vessel Coronary Artery Disease Patients: HIJ-PROPER Sub-study

Masataka Ogiso（Department of Cardiology, Tokyo Women’s Medical University, Tokyo）OE33-6 Impacts of Prehospital 12-Lead ECG Transmission System in the Management of Acute

Myocardial Infarction in the Rural Area of Japan

Kiyotaka Hao（Tohoku University Graduate School of Medicine, Department of Cardiovascular Medicine, Sendai）OE33-7 Fractional Flow Reserve-guided Percutaneous Coronary Intervention for Intermediate Severity

Coronary Lesions in Patients with Hemodialysis

Hiroyuki Hikita（Cardiovascular Center, Yokosuka Kyosai Hospital, Yokosuka）OE33-8 Clinical Characteristics and Angiographic Manifestation in Patients with Catheter-induced

Spasm in the Proximal Right Coronary Artery

Shozo Sueda（Ehime Prefectural Niihama Hospital, Niihama）OE33-9 VEGF-D as a Predictor of Total Mortality in Patients with Suspected or Known Coronary Artery

Disease: From the ANOX Study

Hiromichi Wada（Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto）

Oral Presentation (English) 34 (VD/RF)


Metabolic Syndrome/Lipid Disorders

Chairpersons：Sang-Hyun Kim（Seoul Boramae Hospital, Seoul National University College of Medicine, Korea）Atsushi Nohara（Kanazawa University Health Service Center, Kanazawa）

OE34-1 The Association between Factors Related to Lean and Cardiovascular Events in Patients with

Cardiovascular Risk

Shinichi Toriumi（Cardiovascular Medicine, Jichi Medical University, Shimotsuke）OE34-2 Impact of Longitudinal Changes in Metabolic Syndrome Status over Two Years on 10-year

Incident Type 2 Diabetes Mellitus

Kwang K. Koh（Gachon University Gil Hospital, Korea）OE34-3 Impact of Serum Lp (a) on the Risk of Coronary Artery Disease in Japanese Population

Tetsuo Nishikawa（Department of Cardiology, Kanazawa University School of Medicine, Kanazawa）OE34-4 Clinical Characteristics and Cardiovascular Outcomes in Severe Familial Hypercholesterolemia

Defined by the International Atherosclerosis Society Criteria

Sayaka Funabashi（Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita）OE34-5 Efficacy of the PCSK9 Inhibitor for Lipid-rich Coronary Plaque Reduction: A Near-infrared

Spectroscopy Analysis

Hideaki Ota（Department of Cardiology, Gifu Heart Center, Gifu）OE34-6 Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Coronary Artery and

Internal Thoracic Artery

Ryosuke Numaguchi（Department of Cardiovascular Surgery, Sapporo Medical University School of Medicine,Sapporo）

OE34-7 Visceral Fat Accumulation is Independently Associated with Right Ventricular Dysfunction in

General Population

Naoko Sawada（Department of Cardiovascular Medicine, The University of Tokyo, Tokyo）OE34-8 Biased Adipocyte Differentiation Induce Visceral Adipose Inflammation in Aging and Obesity

Ryuzaburo Yuki（Department of Disease Biology and Molecular Medicine, Chiba University, Chiba）OE34-9 Computed Tomography Myocardial Perfusion Imaging for Detection of Coronary Micro

Vascular Dysfunction and Myocardial Fibrosis in Diabetes Patients

Kentarou Tanaka（Department of Cardiology, New Tokyo Hospital, Matsudo）

March

31

PM

430

Oral Presentation (English) 35 (VD/RF)


Kidney/CKD

Chairpersons：Takafumi Okura（Department of Community and Emergency Medicine, Ehime University Graduate School of Medicine, Toon）Eitaro Kodani（Department of Internal Medicine and Cardiology, Nippon Medical School Tama-Nagayama Hospital, Tama）

OE35-1 Growth Differentiation Factor-15 Predicts Total Mortality in Patients with Chronic Kidney

Disease and Stable Coronary Heart Disease: The ANOX Study

Hiromichi Wada（Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto）OE35-2 Impact of Kidney Function, Ticagrelor and Genetic Polymorphism on High Platelet Reactivity

Weon Kim（Kyung Hee University Hospital, Korea）OE35-3 Role of Anemia and Proteinuria in the Development of Renal Function Deterioration in General

Population with Preserved Glomerular Filtration Rate

Hiroyuki Kiriyama（Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo,Tokyo）

OE35-4 Association between Urinary Angiotensinogen and AKI among Patients Hospitalized with

Worsening Heart Failure

Shota Yokoyama（Department of Cardiorenal and Cerebrovascular Medicine, Kagawa University, Kagawa）OE35-5 Impact of Bleeding Events in Patients on Chronic Hemodialysis Receiving Dual Antiplatelet

Therapy

Takahiro Hayashi（Department of Cardiology, Shonan Kamakura General Hospital, Kamakura）OE35-6 Estimated Glomerular Filtration Rate as a Predictor of Mortality and Morbidity in Patients

Visiting a Cardiovascular Hospital: Shinken Database Analysis

Katsunori Fukumoto（Cardiovascular Institute, Tokyo）OE35-7 Impact of Chronic Kidney Disease on Aortic Artery Disease-Related Mortality: A Nationwide

Community-based Prospective Cohort Study

Yoichiro Otaki（Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine,Yamagata）

OE35-8 Circulating FABP4 is Eliminated by the Kidney via Glomerular Filtration Followed by Megalin-

mediated Reabsorption

Tatsuya Iso（Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi）OE35-9 The Prognostic Impact of Urinary Liver-type Fatty Acid-binding Protein for Acute Kidney Injury

in Patients Undergoing Primary PCI for AMI

Keiichi Hishikari（Department of Cardiovascular Center, Yokosuka Kyosai Hospital, Yokosuka）

Oral Presentation (English) 36 (A)

March 31 (Sun) 13：30－15：00414＋415, 4F, Conference CenterAF, Ablation, Method

Chairpersons：Yoshiaki Kaneko（Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi）Yu-ki Iwasaki（Department of Cardiovascular Medicine, Nippon Medical School, Tokyo）

OE36-1 The Role of Ethanol Ablation for Marshall Bundle Epicardial Connections in Atrial Tachycardias

Following Atrial Fibrillation Ablation

Takeshi Kitamura（Department of Electrophysiology, LIRYC, Bordeaux University, CHU de Bordeaux, Bordeaux,France）

OE36-2 The Patients who Need Substrate Modifications despite Only Having Paroxysmal Atrial

Fibrillation

Yosuke Hayashi（Department of Cardiology, Yokosuka Kyosai Hospital, Yokosuka）OE36-3 Clinical Investigation of High-Power and Short-Duration of Radiofrequency Energy Application

for Atrial Fibrillation Ablation: Prospective Randomized Trial

Tatsuhiko Hirao（Department of Cardiology, Japan Red Cross Yokohama City Bay Hospital, Yokohama）OE36-4 Impact of Different Radiofrequency Power Settings on Tissue Temperature Profiles under the

Same Ablation Index

Makoto Takemoto（Department of Cardiology, Kobe University Hospital, Kobe）

March

31

PM

431

OE36-5 Why Do Female Patients with Atrial Fibrillation More Frequently Have Low-voltage Zones

(LVZs) in the Left Atrium?

Kana Nakashima（Department of Cardiovascular Medicine Saga University, Saga）OE36-6 Acute Effect of Chemical Ablation to the Vein of Marshall for Atrial Fibrillation in Repeat

Multiple Procedures

Shu Yamashita（Department of Cardiology, National Hospital Organization Disaster Medical Center, Tachikawa）OE36-7 The Outcomes of Catheter Ablation for Hemodialysis Patients with Atrial Fibrillation

Yuki Shimizu（Cardiovascular Center, Yokosuka Kyosai Hospital, Yokosuka）OE36-8 Is It Necessary to Eliminate Adenosine Triphosphate Induced Non-pulmonary Vein Foci after a

Pulmonary Vein and Superior Vena Cava Isolation?

Tadahiro Matsumoto（Division of Cardiology, Kimitsu Chuo Hospital, Kisarazu）OE36-9 Efficacy of Right Atrial Substrate Modification for Atrial Fibrillation in Adults with Congenital

Heart Disease

Suguru Nishiuchi（Department of Cardiology, Tenri Hospital, Tenri）

March

31

PM

432

一般演題口述（日本語）35 (A)3月 31日（日） 13：30－15：00会議センター 3階「311＋312」CRT/ICD

座長：佐藤俊明（杏林大学不整脈先進治療学研究講座）安藤献児（小倉記念病院循環器内科）

OJ35-1 Clinical Significance of Precedent Asymptomatic Non-sustained Ventricular Tachycardias on

Subsequent ICD Interventions and Heart Failure Hospitalization in Primary Prevention Patients

牧元久樹（Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University,Germany）

OJ35-2 Outcome after Implantation of Subcutaneous Implantable Cardioverter Defibrillator:

Comparison with that of Transvenous Implantable Cardioverter Defibrillator

劔卓夫（済生会熊本病院心臓血管センター循環器内科不整脈先端部門）OJ35-3 Implantable Cardioverter Defibrillator is Required for Patients with Cardiac Sarcoidosis and

Atrioventricular Block?

佐藤泰貴（国立循環器病研究センター心臓血管内科）OJ35-4 Potential Risk of Bradyarrhythmias in Patients with Hypertrophic Cardiomyopathy and

Implantable Cardioverter Defibrillator Indication

中須賀公亮（名古屋市立大学心臓・腎高血圧内科学）OJ35-5 CRT-P versus CRT-D: Case Matched Analysis of Long-term Survival in Real World

梶山貴嗣（千葉大学循環器内科学）OJ35-6 Impact of Atrial Fibrillation on Mortality in Patients with Implantable Cardioverter

Defibrillators: Sub-analysis from the NIPPON Storm Study

丸山将広（近畿大学循環器内科学）OJ35-7 Impact of Underlying Heart Disease on Electrical Storm Incidence in Patients with Moderately

Impaired Ventricular Function: A Nippon Storm Sub-study

渡邉昌也（北海道大学病院循環器内科）OJ35-8 The Risk Factors of Inappropriate Implantable Cardioverter-Defibrillator Therapy in Japan: A

Sub Analysis of NIPPON Storm Study

西井伸洋（岡山大学医歯薬学総合研究科先端循環器治療学講座）OJ35-9 ICD Therapy in Patients with Ischemic Heart Disease in the Nippon Storm Study

近藤祐介（千葉大学不整脈先端治療学）

一般演題口述（日本語）36 (A)3月 31日（日） 15：10－16：40会議センター 3階「311＋312」AF, Predictors

座長：武居明日美（神戸労災病院循環器内科）田邊康子（旭川医科大学循環・呼吸・神経病態内科学分野）

OJ36-1 Predictive Power of Left Atrial Reverse Remodeling for Long-term Recurrence after Catheter

Ablation: Paroxysmal versus Non-paroxysmal Atrial Fibrillation

岡崇史（桜橋渡辺病院）OJ36-2 Association of Left Atrial Conduction Time with Clinical Outcome after Pulmonary Vein

Isolation for Persistent Atrial Fibrillation without Low-voltage Area

川尻紘平（東京都立広尾病院循環器科）OJ36-3 Early Evaluation of Heart Rate Variation after Catheter Ablation Predicts the Recurrence on

Chronic Phase in Patients with Atrial Fibrillation

蘆田健毅（兵庫医科大学循環器内科）OJ36-4 Reduced Left Atrial Function is Associated with Poor Long-term Outcome after Catheter

Ablation to Paroxysmal Atrial Fibrillation

岡崇史（桜橋渡辺病院）OJ36-5 Characteristics of the Lesions Created by Short-duration RF Application: Moderate-lesion on

the Endocardial Surface and Dense-lesion Just below

齋藤修（新潟大学保健学科）

March

31

PM

433

OJ36-6 The Predictor of Atrial Reverse Remodeling after Catheter Ablation in Patients with Non-

Paroxysmal Atrial Fibrillation

田中友望（高槻病院不整脈センター）OJ36-7 Difference in the Mechanism of Early and Late Phase Recurrent Atrial Fibrillation Following

Catheter Ablation Procedure

金澤尚徳（熊本大学不整脈先端医療寄附講座）OJ36-8 Estimated Glomerular Filtration Rate and Proteinuria Synergistically Predict Atrial Fibrillation,

Thromboembolism, Heart Failure Events, and Mortality: Shinken Database Analysis

大井田充範（心臓血管研究所循環器科）OJ36-9 The Impact of Ablation with Guidance of Lesion Size Prediction Index on Clinical Outcome of

Atrial Fibrillation Ablation

松尾征一郎（東京慈恵会医科大学葛飾医療センター循環器内科）

一般演題口述（日本語）37 (CAD)3月 31日（日） 13：30－15：00会議センター 3階「313＋314」Coronary Revascularization/PCI (DES)

座長：道下一朗（横浜栄共済病院内科）森田有紀子（国立病院機構相模原病院循環器内科）

OJ37-1 Difference of Very Late Stent Thrombosis Mechanism Assessed by Optical Coherence

Tomography among 1st and 2nd Drug-eluting Stent and BMS

猪野靖（和歌山県立医科大学循環器内科学）OJ37-2 Dissimilar Impacts of the 1-year Angioscopic Findings on Long-term Clinical Events between

the First-generation DES and the Second-generation CoCr-EES

尾松卓（大阪警察病院循環器内科）OJ37-3 The Comparison of Healing 1-month and 1-year after Percutaneous Coronary Intervention

among CoCr- EES, BP-EES and BP-SES

田谷侑司（立川綜合病院）OJ37-4 Abluminal Coating Stent versus Conformal Coating Stent: Termination of These Inflammatory

Response Associated with Neointimal Healing in Porcine Coronary Model

森雅之（金沢大学循環器病態内科学）OJ37-5 Prospective Interventional Registry of Short-term Dual Anti-platelet Treatment after DES

Implantation in Patients with Atrial Fibrillation Requiring Oral Anti-coagulation Therapy

堀江和紀（仙台厚生病院循環器内科）OJ37-6 Long-term Outcome Comparison of Drug-eluting Stents and Bare-Metal Stents in Patients

with High Bleeding Risk

春原大輔（信州大学循環器内科学）OJ37-7 Five-year Clinical Outcomes and Predictors of Target Lesion Revascularization after

Everolimus-eluting Stent Implantation

為清博道（土谷総合病院循環器内科）OJ37-8 Influence of Drug-coated Stent Implantation on Structural and Functional Vascular Healing

Response: An Optical Coherence Tomography and Acetylcholine Testing Study

田丸裕人（東宝塚さとう病院循環器内科）OJ37-9 Impact of Post-stent Irregular Protrusion on In-stent Neoatheroscrelosis Formation after Third-

generation Drug-eluting Stent Implantation: Optical Coherence Tomography Study

佐貫仁宣（産業医科大学第二内科）

March

31

PM

434

一般演題口述（日本語）38 (CAD)3月 31日（日） 15：10－16：40会議センター 3階「313＋314」Coronary Revascularization/PCI (Restenosis/Others)

座長：畑明宏（豊島病院循環器内科）秋田孝子（総合高津中央病院心臓血管センター）

OJ38-1 Triglyceride Deposit Cardiomyovasculopathy, a Novel-type Atherosclerosis with Triglyceride

Deposition in Coronary Arteries, as New-found Risk Factor of Restenosis after Stent-

Implantation

中野雄介（愛知医科大学循環器内科）OJ38-2 Predictive Value of Logistic Clinical SYNTAX Score for the Prediction of 5-year Outcome after

Percutaneous Coronary Intervention from SHINANO Registry

柏木大輔（信州大学循環器内科学）OJ38-3 The Impact of Hyperuricemia on Low-BMI Patients after Percutaneous Coronary Intervention:

From SHINANO Registry

永江歩（信州大学病院循環器内科）OJ38-4 Two-Year Outcomes after Excimer Laser Coronary Angioplasty and Paclitaxel-coated Balloon

Combination Therapy for Drug-eluting Stent Restenosis

檜垣忠直（広島市立広島市民病院循環器内科）OJ38-5 Impact of Procedural Success and Left Ventricular Ejection Fraction on Long-term Clinical

Outcome of Coronary Intervention for Chronic Total Occlusion

田中裕之（倉敷中央病院循環器内科）OJ38-6 Outcomes of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention:

5-year Outcomes from Shinano-registry

丸山拓哉（長野県厚生連篠ノ井総合病院循環器内科）OJ38-7 Vascular Response of In-Stent Restenosis Lesions after Balloon Dilation; An Optical Coherence

Tomography Analysis

山本航（東宝塚さとう病院循環器内科）OJ38-8 5-year Outcomes in Patients with Peripheral Artery Disease Undergoing Percutaneous

Coronary Intervention from the SHINANO Registry

橋詰直人（長野県厚生連篠ノ井総合病院循環器内科）OJ38-9 Impaired High-density Lipoprotein Cholesterol Efflux Capacity for Development of Denovo

Coronary Stenosis under Pharmacological Secondary Prevention for Coronary Artery Disease

宇梶僚晟（獨協医科大学埼玉医療センター循環器内科）

一般演題口述（日本語）39 (CAD)3月 31日（日） 15：10－16：40会議センター 3階「315」ACS/AMI (Clinical/Treatmet)

座長：神谷春雄（名古屋第一赤十字病院循環器科）小菅雅美（横浜市立大学市民総合医療センター循環器内科）

OJ39-1 A Novel Approach for Cardioprotection in Patients with ST-Segment Elevation Myocardial

Infarction

小山卓史（さいたま市立病院循環器内科）OJ39-2 Clinical Characteristics and In-hospital Outcome of Patients with Acute Myocardial Infarction

Complicated by Complete Atrioventricular Block

新里広大（宮崎市郡医師会病院心臓病センター循環器科）OJ39-3 The E-wave Propagation Index is a Novel Echocardiographic Parameter to Predict Left

Ventricular Thrombus in Patients with Acute Myocardial Infarction

竹本創（広島市民病院循環器科）OJ39-4 Different Vascular Reaction to Everolimus-eluting Stents Implantation between Stable Angina

and ST Elevation Myocardial Infarction: Insights fromMECHANISM Studies

築山義朗（神戸大学循環呼吸器病態学）OJ39-5 Acute Phase of Post-procedural High Platelet Reactivity with Loading Dose of Prasugrel

Correlates Clinical Outcomes of Acute Coronary Syndrome

黒田和宏（岡山市立市民病院循環器内科）

March

31

PM

435

OJ39-6 The Impact of Low Diastolic Blood Pressure on 30-day Mortality in Patients with Acute


浅野拓（東京都CCUネットワーク/聖路加国際病院心血管センター）OJ39-7 The Efficacy of Early Revascularization for the Elderly Non-ST-Elevation Myocardial Infarction

Patients with Heart Failure: Tokyo CCU Network Cohort Analysis

藤本肇（東京都CCUネットワーク学術委員会東京都健康長寿医療センター循環器内科）OJ39-8 The Outcome of Acute Myocardial Infarction in over the Age of Eighty with/without Coronary

Intervention: From K-ACTIVE

櫻井馨（新百合ヶ丘総合病院循環器内科）OJ39-9 Incidence, Characteristics, and Outcome of Cardiac Rupture in Patients with AMI Treated with

Primary PCI

花田賢二（弘前大学循環器内科）

一般演題口述（日本語）40 (HF/CM)3月 31日（日） 13：30－15：00会議センター 4階「418」Heart Failure/Cardiomyopaty (Basic)

座長：竹藤幹人（名古屋大学循環器内科）吉田陽子（新潟大学循環器学分野）

OJ40-1 Quantification of DNA Damage in Heart Tissue as a Novel Prediction Tool for Therapeutic

Prognosis

候聡志（東京大学循環器内科）OJ40-2 Activated Alternative Complement Pathway is Responsible for Right Heart Failure and

Arrhythmia

伊藤章吾（慶應義塾大学循環器内科）OJ40-3 mRNA Binding Protein ZFP36L2 is Required for Normal Cardiac Function through p53-

dependent mTORC1 Regulation

神津英至（札幌医科大学循環器・腎臓・代謝内分泌内科学講座）OJ40-4 Cavin-2 Deficiency Attenuates Myofibroblast Differentiation and Cardiac Fibrosis in Pressure

Overloaded Hearts

樋口雄亮（京都府立医科大学循環器内科学）OJ40-5 Relation between Effector Memory T Cells with Activation of Kv1.3 and Severity of Heart

Failure

野村秀仁（東京女子医科大学循環器内科）OJ40-6 Loss of Endogenous Apelin Augments Angiotensin II-mediated Cardiac Remodeling

佐藤輝紀（秋田大学循環器内科学）OJ40-7 Impaired Barrier Function of Gut Epithelium in a Mouse Model of Heart Failure

嵯峨亜希子（東京大学循環器内科）OJ40-8 Adrenomedullin-RAMP Systems Protect Cardiac Homeostasis against Cardiovascular Stresses

崔南奇（信州大学循環病態学教室）OJ40-9 Inhibition of Xanthine Oxidase in Type 2 Diabetic Rats Ameliorates Pressure Overload-induced

Diastolic Dysfunction

井垣勇祐（札幌医科大学循環器腎臓代謝内分泌内科学講座）

一般演題口述（日本語）41 (HF/CM)3月 31日（日） 15：10－16：40会議センター 4階「418」Cardiac Arrest/ACLS/Transplantation/LVAD

座長：篠岡太郎（東京医科歯科大学循環器内科）世良英子（大阪大学循環器内科学）

OJ41-1 Prognostic Value of Early Advanced Life Support by Emergency Medical Services in Out-of-

hospital Cardiac Arrest: JCS-ReSS Study

中野宏己（東京医科大学循環器内科）OJ41-2 Enlarging Cannula Size of VA ECMO for CPA Patients Improves Efficiency of ECMO and 30-day

Prognosis

権藤公樹（福岡県済生会福岡総合病院循環器内科）

March

31

PM

436

OJ41-3 Benefit of LV Unloading by Means of Impella in Patients with Refractory Cardiogenic Shock for

ST-Elevation Myocardial Infarction (STEMI)

中田淳（日本医科大学集中治療室）OJ41-4 Chronic Total Occlusion Dependent on Infarct-related Artery was Associated with In-hospital

Mortality of Sudden Cardiac Arrest Acute Coronary Syndrome Patients

篠内和也（国立病院機構大阪医療センター循環器内科）OJ41-5 The Impact of Coronary Artery Disease to Predict Mortality and Neurological Outcome in Post-

cardiac Arrest Patients

松田隼治（さいたま赤十字病院循環器科）OJ41-6 Accurate Quantification Method of Aortic Insufficiency during Left Ventricular Assist Device

Support by Thermodilution Analysis

秋山大地（東京大学心臓外科）OJ41-7 Prediction of Right Ventricular Failure after Left Ventricular Assist Device Implantation Using

Machine Learning of Preoperative Hemodynamics

佐村高明（大阪大学心臓血管外科）OJ41-8 Optical Coherence Tomography Assessment of Coronary Plaque Morphology Associated with

Lesion Progression in Cardiac Transplant Recipients

白記達也（大阪大学循環器内科学）OJ41-9 Impact of Bridge to Bridge Strategies on the Outcome in Patients with Implantable

Continuous-flow Left Ventricular Assist Devices

中島誠子（国立循環器病研究センター移植医療部）

一般演題口述（日本語）42 (VD/RF)3月 31日（日） 13：30－15：00会議センター 4階「419」Vascular Disease (Therapy)

座長：上田みどり（榊原記念クリニック循環器科）山田浩之（京都府立医科大学循環器・腎臓内科学）

OJ42-1 Effect of Smoking on Yearly Increase of Central Blood Pressure

髙瀨浩之（遠州病院内科）OJ42-2 Sex Differences in Clinical Characteristics and Outcomes of Patients with Venous


芳川裕亮（京都大学循環器内科学）OJ42-3 Long-term Cerebral Infarction and Cerebral Hemorrhage after Thoracic Endovascular Repair

松尾武彦（倉敷中央病院心臓血管外科）OJ42-4 Comparison of Safety and Efficacy of TAVI Using Self-expanding Devices in Patients with

Bicuspid versus Tricuspid Aortic Valves: One-year Follow-up

向井隆（大阪大学循環器内科学）OJ42-5 One-year Outcomes of Endovascular Therapy for Aortoiliac Lesions

山内靖隆（総合高津中央病院心臓血管センター）OJ42-6 Clinical Implications of Geriatric Nutritional Risk Index for Critical Limb Ischemia Patients who

Underwent Endovascular Therapy

安里哲矢（宮崎市郡医師会病院心臓病センター循環器科）OJ42-7 Favorable Effects of Revascularization on Muscle Volume, Glucose Tolerance, and

Apolipoproteins in Peripheral Artery Disease by Endovascular Therapy

宮國知世（日本医科大学千葉北総病院循環器センター）OJ42-8 Gender Difference in In-hospital Mortality for Acute Aortic Dissection: Analysis from the Tokyo

Acute Aortic Super-network Database

高橋寿由樹（東京都CCUネットワーク学術委員会、東京都済生会中央病院）OJ42-9 Impact of Vessel Size for the Long-term Patency Following Self-expanding Nitinol Stent

Implantation in the Superficial Femoral Artery

三木孝次郎（兵庫医科大学循環器内科冠疾患内科）

March

31

PM

437

一般演題口述（日本語）43 (VD/RF)3月 31日（日） 15：10－16：40会議センター 4階「419」Vascular Disease (Others)

座長：小林成美（神戸大学内科学講座循環器内科学分野）石川かおり（香川大学総合内科）

OJ43-1 Impact of Obstructive Sleep Apnea on Inter-arm Blood Pressure Difference: A Large Sleep

Cohort Study

椎名一紀（東京医科大学循環器内科学分野）OJ43-2 Visit-to-visit Blood Pressure Variability, Carotid Artery Hemodynamics, and Their Effects on

Cognitive Dysfunction

永井道明（広島市立安佐市民病院循環器内科）OJ43-3 Latent Left and Right Ventricular Dysfunction in Patients with Obstructive Sleep Apnea:

Impact of Continuous Positive Airway Pressure Therapy

神田貴弘（浜松赤十字病院循環器科）OJ43-4 Galectin-3 Predicts Impaired Membrane Microviscosity of Red Blood Cells and Microcirculatory

Dysfunction in Hypertensive Subjects by a Nitric Oxide-dependent Mechanism

津田和志（関西医療大学循環器代謝内科学）OJ43-5 Prognostic Impact of Periodic Leg Movements during Sleep on Patients with Heart Failure

菅野優紀（福島県立医科大学循環器内科学講座）OJ43-6 Prognostic Impact of Restless Legs Syndrome on Patients with Heart Failure

三阪智史（福島県立医科大学循環器内科学講座）OJ43-7 Restored Low Density Lipoprotein Uptake in Gene-corrected iPSC-derived Hepatocytes from

Homozygous Familial Hypercholesterolemia

岡田寛史（金沢大学循環器病態内科学）OJ43-8 The Interaction between Duration of Hypoxia and Muscle Sympathetic Nerve Activity in

Obstructive Sleep Apnea Patients

濱岡卓人（金沢大学先進予防医学研究科システム生物学分野）OJ43-9 Carotid Flow Augmentation Has Differential Characteristics from Aortic Pressure

Augmentation: Clinical Implications for Cerebral White Matter Hyperintensities with

Advancing Age

橋本潤一郎（宮城教育大学保健管理センター）

March

31

PM

438

Best Poster Session 6 (A)

March 31 (Sun) 14：00－14：50Exhibition Hall

Arrhythmia

Chairpersons：Masaomi Kimura（Advanced Management of Cardiac Arrhythmia, Hirosaki University Graduate School of Medicine, Hirosaki）Toshiya Kojima（Department of Cardiovascular Medicine, The University of Tokyo, Tokyo）

BP6-1 A Novel TMEM168 Gene Mutation in Familial Brugada Syndrome Attenuates Na+ Channel

Function by Modulating Nav1.5 Expression

Dimitar P. Zankov（Division of Molecular Medical Biochemistry, Department of Biochemistry and Molecular Biology,Shiga University of Medical Science, Otsu）

BP6-2 Association of GJA-1 Gene Polymorphisms with Heart Rate Control in Patients with Atrial

Fibrillation

Sho Okamura（Department of Cardiology, Hiroshima University School of Medicine, Hiroshima）BP6-3 Overlapping Sick Sinus Syndrome Associated with SCN5A Mutations in Patients with Brugada

Syndrome

Asami Kashiwa（Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto）BP6-4 Withdrawn

BP6-5 Major Determinants for the Progression of Renal Function, and Its Prognostic Impact in

Japanese Patients with Atrial Fibrillation

Keiichiro Kuronuma（Kawaguchi Municipal Medical Center, Kawaguchi）BP6-6 High Energy Requirement for Internal Cardioversion may Indicate Post-ablation Recurrence of

Long-standing Persistent Atrial Fibrillation

Hiroki Sugiyama（Department of Cardiology, Ogaki Municipal Hospital, Ogaki）BP6-7 Poor Risk Assessment by Coronary Interventionists for Sudden Cardiac Death in Patients with

Ischemic Heart Disease after Coronary Revascularization

Morihiko Takeda（Department of Cardiovascular Medicine, International University of Health and Welfare Hospital,Nasushiobara）

March

31

PM

439

Poster Session (English) 65 (CAD)


Intravascular Imagings

Chairpersons：Hiroyuki Okura（Department of Cardiology, Gifu University Graduate School of Medicine, Gifu）Shinjo Sonoda（The 2nd Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu）

PE65-1 Association between Calcified Nodules and Coronary Artery Calcification Score in Patients

with OCT-guided PCI

Makoto Watanabe（Department of Cardiology, Nara Medical University, Kashihara）PE65-2 Detection of Plaque Rupture by High-definition Intravascular Ultrasound in Patients with Acute

Coronary Syndrome

Hirofumi Ohashi（Department of Cardiology, Aichi Medical University, Nagakute）PE65-3 The Utility of Near-Infrared Spectroscopy (NIRS) to Detect Lipid Core Plaques (LCPs) Leading

to Peri Procedural Myocardial Injury (Peri-MI)

Takaaki Matsuoka（Department of Cardiovascular Medicine, Chiba University, Chiba）PE65-4 Aortic Angioscopy for the Prediction of Embolic Stroke Associated with Transaortic Valvular

Implantation

Makoto Natsumeda（Department of Cardiology, Tokai University School of Medicine, Isehara）PE65-5 Neo-intimal Calcification in Previously Implanted Bare-metal Stent Disturbs Newly Implanted

Drug-eluting Stent Expansion in Target Lesion Revascularization

Takahiro Watanabe（Department of Cardiology, Yokohama Rosai Hosipital, Yokohama）PE65-6 Serial Assessment of Vascular Response by Optical Coherence Tomography between Durable

vs. Bioabsorbable Polymer EES in ACS Patients

Setsu Nishino（Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu）PE65-7 Impact of High-sensitivity Cardiac Troponin Elevation in Relation to Diagnostic Invasive

Intracoronary Imaging for the Assessment of Coronary Artery Disease

Kohshi Setoyama（The Second Department of Internal Medicine, University of Occupational and EnvironmentalHealth, Kitakyusyu）

Poster Session (English) 66 (CAD)


Thromboembolism

Chairpersons：Tetsuya Watanabe（Yao Municipal Hospital, Yao）Yoshihiro Dohi（Devision of Cardiology, Kure Kyosai Hospital, Kure）

PE66-1 Rivaroxaban, A Direct Inhibitor of FXa, Attenuated Diabetes-induced Endothelial Dysfunction

by Inhibiting FXa-protease Activated Receptor 2 Signaling

Tran Phuong Pham（Department of Cardiovascular, Tokushima University, Tokushima）PE66-2 The Relationship between Varicose Veins and the Risk of Recurrent Venous


Hidenori Yaku（Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto）PE66-3 Impact of VTE-BLEED Score to Predict Major Bleeding and Other Adverse Event for Venous

Thromboemobolism

Junya Honda（Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba）PE66-4 History of Venous Thromboembolism Correlated with The Onset of Heart Failure in Cancer

Patients

Shinji Satoh（Department of Cardiology, Saiseikai Imabari Hospital, Imabari）PE66-5 The Characteristics and the Risk Factor of Thrombosis in Patients with Atrial Fibrillation

Taking Reduced Dose of DOAC

Yasuaki Tsumagari（Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba）PE66-6 Specialty-related Differences between Cardiologists and General Practitioners in the

Management of Atrial Fibrillation

Taro Nihei（Department of Cardiology, Ishinomaki Municipal Hospital, Ishinomaki）PE66-7 The Correlations between Anti-factor Xa Activity Values and PT/APTT at Peak and Trough

Times in Patients on Rivaroxaban Therapy

Ryohei Ono（Department of Cardiology, Matsudo City General Hospital, Matsudo）

March

31

PM

440

Poster Session (English) 67 (A)


Ventricular Tachyarrhythmia 1

Chairpersons：Yasuya Inden（Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya）Toshiko Nakai（Department of Medicine, Division of Cardiology, Nihon University School of Medicine, Tokyo）

PE67-1 Impact of the Contemporary Prophylactic Catheter Ablation for Ventricular Tachycardia in

Patients with Structural Heart Disease

Takeshi Kitamura（Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo）PE67-2 Electrocardiographic Features of Ventricular Arrythmias Originating from The Junction of Left

and Right Coronary Cusp

Hirotaka Muramoto（Hiratsuka Kyosai Hospital, Kanagawa）PE67-3 Comparison of Impedance Differences on the Basis of Ground Catheter Tip Size during Bipolar

Ablation for Intramural Ventricular Tachycardia

Iwanari Kawamura（Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo）PE67-4 Short-term Outcomes of Epicardial Substrate-based Ablation in the Prevention of Recurrences

of Ventricular Fibrillation in Patients with Brugada Syndrome

Akira Kimata（Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba）PE67-5 Catheter Ablation for Septal Ventricular Tachycardia in the Patients with Non-ischemic

Cadiomyopathy: Incidence, Recurrence, and Substrate Characteristics

Masayuki Hattori（Department of Cardiology, University of Tsukuba Hospital, Tsukuba）




Chairpersons：Masahiko Takagi（Division of Clinical Arrhythmia, Kansai Medical University Medical Center, Moriguchi）Masato Watanuki（Department of Cardiology, Hikone Municipal Hospital, Hikone）

PE68-1 Characteristics of 12-lead ECG in Patients with Outflow Tract Ventricular Arrhythmias

Considering Ethanol Injection into Coronary Vein

Nobuo Ishiguro（Nagoya Tokushukai General Hospital, Kouzouji）PE68-2 Initial Experience of Ablation for Outflow Tract Ventricular Arrhythmia Using Non-fluoroscopic

Catheter Visualization System

Yumi Katsume（Department of Cardiology, Kyorin University School of Medicine, Tokyo）PE68-3 Clinical Characteristics and Outcomes of Catheter Ablation for Ventricular Tachycardia in

Cardiac Sarcoidosis: Significant Role of Aneurysm for Arrhythmogenic Substrate

Keita Mamiya（Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya）PE68-4 Fast-fourier Transform Analysis during SR as an Optimal Ablation Site Indicator of Outflow

Tract Ventricular Arrhythmias when They Hardly Appear

Hitoshi Hachiya（Cardiovascular Division, Tsuchiura Kyodo Hospital, Tsuchiura）PE68-5 Transseptal Approach is Feasible and Effective in Ablating Ventricular Tachycardia Originating

from Left Ventricle

Kazuo Sakamoto（Department of Cardiology, Kyushu University Hospital, Fukuoka）




Chairpersons：Atsunobu Kasai（Department of Cardiology, Ise Red Cross Hospital, Ise）Kaoru Tanno（Department of Cardiology, Showa University Koto-Toyosu Hospital, Tokyo）

PE69-1 Characteristics and Short-term Prognosis of Patients with Ventricular Arrhythmias: Five Years

Analysis from Tokyo CCU Network Registry

Akira Ueno（Tokyo CCU Network Scientific Committee, Tokyo）

March

31

PM

441

PE69-2 Programmed Electrical Stimulation can Predict Prognosis in Asymptomatic Patients but not in

Symptomatic Patients with Brugada Syndrome

Saori Tsukuda（Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistryand Pharmaceutical Sciences, Okayama）

PE69-3 Long-term Follow up Ventricular Tachycardia Patients with Preserved Cardiac Function: From

Japanese Cardiac Sarcoidosis Nationwide Questionnaire Survey

Kenzaburo Nakajima（National Cerebral and Cardiovascular Center, Suita）PE69-4 Combined Assessment of Novel Ambulatory-based Late Potentials and Heart Rate Turbulence

in Identifying at Risk in Patients after Myocardial Infarction

Kenichi Hashimoto（Department of Intensive Care Medicine, National Defense Medical College, Saitama）PE69-5 Usefulness of Wearable Cardioverter Defibrillator as a Bridge Therapy

Noriko Kikuchi（Department of Cardiology, Tokyo Women’s Medical University, Tokyo）PE69-6 Duration of Heart Failure History and Enlarged Left Ventricle are Associated with Ventricular

Arrhythmia after LVAD Implantation

Daisuke Yakabe（Department of Cardiology, National Hospital Organization Kyushu Medical Center, Fukuoka）PE69-7 Frequency Gradient during Rotor Activity in Human Ventricular Fibrillation

Takeshi Kitamura（Department of Electrophysiology, LIRYC, Bordeaux University, CHU de Bordeaux, France）

Poster Session (English) 70 (HF/CM)


Pulmonary Circulation 2

Chairpersons：Noriaki Emoto（Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe）Hiroshi Wada（Department of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Saitama）

PE70-1 Chronic Inhibition of Toll-Like Receptor 9 Ameliorated the Development of Pulmonary Arterial

Hypertension by Reducing Perivascular Inflammation in Rats

Tomohito Ishikawa（Department of Cardiovascular Medicine, Graduate School of Medical Sciences, KyushuUniversity, Fukuoka）

PE70-2 Endothelin-1 Upregulates Activin Receptor-like Kinase-1 (ALK-1) Expression through Gi-RhoA

Dependent Pathway in Human Pulmonary Arterial Endothelial Cells

Koichi Sugimoto（Department of Pulmonary Hypertension, Fukushima Medical University, Fukushima）PE70-3 Critical Role of INHBA in Pulmonary Arterial Hypertension Development

Gusty Rizky Teguh Ryanto（Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe UniversityGraduate School of Medicine, Kobe）

PE70-4 Metabolomic Analysis in the Lung of Mice with Hypoxia-induced Pulmonary Hypertension

Satoshi Sakai（Department of Cardiology, University of Tsukuba, Tsukuba）PE70-5 Role of BMPR2 Mutation in Monocrotaline-induced Pulmonary Hypertension: Analysis Using

Rats with a Crispr/Cas9-induced Truncating BMPR2 Mutation

Jane C. Kabwe（Mie University Graduate School of Medicine, Tsu）PE70-6 Balloon Pulmonary Angioplasty for Patients with Symptomatic Chronic Thromboembolic

Disease without Pulmonary Hypertension

Yu Taniguchi（Department of Cardiology, Kobe University Graduate School of Medicine, Kobe）

Poster Session (English) 71 (VD/RF)


Vascular Biology 1

Chairpersons：Tomohiro Osanai（Hirosaki University Graduate School of Health Sciences, Hirosaki）Akira Miyamoto（Department of Cardiology, Takatsu General Hospital, Kawasaki）

PE71-1 C1q/TNF-Related Protein 1 Promotes Endothelial Barrier Dysfunction under Disturbed Flow

Xiao Qun Wang（Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China）PE71-2 Important Roles of Endothelium-dependent Hyperpolarization in Coronary Microcirculation

and Cardiac Diastolic Function in Mice

Yosuke Ikumi（Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai）

March

31

PM

442

PE71-3 Marked Impairment of Endothelium-dependent Digital Vasodilatations in Patients with

Microvascular Angina Compared with Those with Vasospastic Angina

Shoko Kajitani（Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai）PE71-4 Combined Lipid Lowering Therapy in Patients with Ischemic Heart Disease and Metabolic

Syndrome

Jamol Uzokov（Republican Specialized Scientific Practical Medical Center of Therapy and Medical Rehabilitation,Uzbekistan）

PE71-5 Minimally Invasive Surgical Treatment of Stanford A Aortic Dissection

Weitie Wang（The Second Hospital of Jilin University, China）PE71-6 FAK Promotes Tissue Destruction in Murine Model of Aortic Dissection

Ryohei Majima（Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School ofMedicine, Fukuoka）

PE71-7 Syk Protects Aortic Tissue from Destruction in Murine Aortic Dissection

Youhei Hashimoto（Department of Internal Medicine, Division of Cardiovascular Medicine, Kurume University Schoolof Medicine, Kurume）

Poster Session (English) 72 (VD/RF)


Vascular Biology 2

Chairpersons：Toshihiro Ichiki（Department of Cardiology, Harasanshin Hospital, Fukuoka）Masato Tsutsui（Department of Pharmacology, Graduate School of Medicine, University of the Ryukyus, Nakagami）

PE72-1 Important Roles of Endothelial Caveolin-1 in Endothelium-dependent Hyperpolarization and

Ischemic Angiogenesis in Mice

Akiyo Ito（Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai）PE72-2 Osteoprotegerin is Up-regulated at the Transition Zone of Abdominal Aortic Aneurysm in

Humans

Toshihiro Tsuruda（Department of Internal Medicine, Circulatory and Body Fluid Regulation, Faculty of Medicine,University of Miyazaki, Miyazaki）

PE72-3 A New Aortic Arch Inclusion Technique with Frozen Elephant Trunk for Type A Aortic

Dissection

Cuilin Zhu（The Second Hospital of Jilin University, China）PE72-4 Gender Differences in Acute Type B Aortic Dissection

Ryuki Chatani（Department of Cardiology, Kurashiki Central Hospital, Kurashiki）PE72-5 A New Aortic Root Reinforcement Technique for Acute Type A Aortic Dissection Surgery

Cuilin Zhu（The Second Hospital of Jilin University, China）PE72-6 Spot Stenting versus Full Coverage Stenting after Endovascular Therapy for Femoropopliteal

Artery Lesions

Yusuke Tomoi（Department of Cardiology, Kokura Memorial Hospital, Kitakyushu）PE72-7 The Impact of Calcium Score of Femoropopliteal Artery after Endovascular Treatment (EVT)

Takahiro Tokuda（Department of Cardiology, Nagoya Heart Center, Nagoya）

Poster Session (English) 73 (SHD)


Valvular Heart Disease 2

Chairpersons：Shinji Miyamoto（Department of Cardiovascular Surgery, Oita University, Yufu）Tomoko Nakao（Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo）

PE73-1 Renal Impairment and CHA2DS2-VASc Score are Associated with Silent Brain Infarction in

Patients with Severe Aortic Stenosis

Soichiro Tamura（Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine,Osaka）

PE73-2 Prognostic Impact of Controlling Nutritional Status (CONUT) Score in Patients with Infective

Endocarditis

Yuki Saito（Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo）

March

31

PM

443

PE73-3 A Real-world Validation of Clinical Prediction Model for Predicting Mortality after

Transcatheter Aortic Valve Implantation

Hiroki Tateishi（Division of Cardiology, Department of Clinical Science and Medicine, Yamaguchi University GraduateSchool of Medicine, Ube）

PE73-4 Influence of the Tilt Angle of Transcatether Aortic Valve Implantation on a New-onset

Conduction Abnormality

Yoshiki Matsuo（Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama）PE73-5 Impact of Mitral Valve Regurgitation among Severe AS Patients

Hiroki Kajiura（Ichinomiya Municipal Hospital, Ichinomiya）PE73-6 Transcatheter Aortic Valve Implantation is Superior to Aortic Valve Replacement in Cardiac

Sympathetic Nerve Activity in Patients with Aortic Stenosis

Tetsuari Ohnishi（Department of Cardiology, Himeji Cardiovascular Center, Himeji）PE73-7 Atrial Functional Tricuspid Regurgitation Due to Persistent Atrial Fibrillation:

Echocardiographic Assessment at around Catheter Ablation Treatment

Kiho Itakura（Department of Cardiology, Hiroshima University Hospital, Hiroshima）

Poster Session (English) 74 (IMG)


ECG

Chairpersons：Kenji Nakai（Iwate Blood Center, Japan Red Cross Society, Morioka）Tadashi Fujino（Department of Cardiology, Policlinico Casilino, Italy）

PE74-1 Can the 12-leads Electrocardiography Itself Predict Prognosis in Patients with Complete Left

Bundle Branch Block?

Masato Shimizu（Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama）PE74-2 Electrocardiogram Findings in Patients with Pectus Excavatum: Relationship with Anatomical

Severity Indicated by the Haller Index and Acquired by Computed-Tomography

Gentaro Koyama（Department of Cardiology, Chiba University School of Medicine, Chiba）PE74-3 P Wave Width is an Electrocardiographic Marker for Recurrence after Catheter Ablation for

Atrial Fibrillation

Daisuke Wakatsuki（Division of Cardiology, Showa University Fujigaoka Hospital, Yokohama）PE74-4 Is It Possible to Recognize Free-wall Implantation of Leadless Pacemaker from an ECG?

Takatsugu Kajiyama（Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine,Chiba）

PE74-5 QT Interval as a Predictor for the Severity and Progression among COPD Patients

Bo Zhou（Respiratory Department, First Affiliated Hospital of Medical College, Xi’an Jiaotong University, China）PE74-6 The Prediction of New-onset Atrial Fibrillation after Cavo-tricuspid Isthmus Dependent Atrial

Flutter Ablation

Yuhi Fujimoto（Department of Cardiovascular Medicine, Nippon Medical School, Tokyo）PE74-7 Impact of Oxidative Stress on the Long-term Heart Rate Variability: Linear vs. Nonlinear Heart

Rate Dynamics

Chan-Hee Lee（Yeungnam University Medical Center, Korea）

Poster Session (English) 75 (IMG)


Nuclear Others

Chairpersons：Shigeru Fukuzawa（Division of Cardiology, Funabashi Municipal Medical Center, Funabashi）Masayoshi Sarai（Department of Cardiology, Fujita Health University School of Medicine, Toyoake）

PE75-1 Phase Analysis Using Low Dose 99mTc Gated-SPECT Detects Significant Late Gadolinium

Enhancement in Patients with Dilated Cardiomyopathy

Sakura Nagumo（Department of Cardiology, Nihon University Hospital, Tokyo）PE75-2 Tc-99m-pyrophosphasphate (PYP) Scintigraphy Diagnosis of Cardiac Amyloidosis: Utilization

of Heart to Contralateral Lung Ratio

Shinro Matsuo（Department of Advanced Preventive Medical Sciences, Graduate School of Kanazawa University,Kanazawa）

March

31

PM

444

PE75-3 Heart Failure with Recovered Ejection Fraction Has Better Cardiac Sympathetic Nerve Function

than Heart Failure with Reduced Ejection Fraction

Yohei Ishibashi（Department of Cardiology, Gunma University School of Medicine, Gunma）PE75-4 Artificial Intelligence-based Risk Model for Predicting 5-year Sudden Cardiac Death and Heart-

failure Death Using I-123 Meta-iodobenzylguanidine

Kenichi Nakajima（Department of Nuclear Medicine, Kanazawa University School of Medicine, Kanazawa）PE75-5 Effect of Transcatheter Aortic Valve Implantation on Cardiac Sympathetic Nervous Function

Assessed by 123I-Metaiodobenzylguanidine Scintigraphy in Patients with Aortic Stenosis

Yoshito Kadoya（Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto）PE75-6 Prognostic Value of 99mTc-ECD Brain Perfusion SPECT in Patients with Atrial Fibrillation and

Dementia

Hidenobu Hashimoto（Department of Cardiovascular Medicine, Department of Internal Medicine, Toho UniversityFaculty of Medicine, Tokyo）

PE75-7 Two Rest Gated Myocardial Perfusion SPECT (GMPS) Acquisitions with a Single Injection of99mTc-tetrofosmin are Useful for CRT Optimization

Shohei Ishikawa（Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University,Kagawa）

March

31

PM

445

ポスターセッション（日本語）105 (CAD)3月 31日（日） 14：50－15：40展示ホールIntravascular Imagings 3

座長：川崎雅規（岐阜ハートセンター循環器内科）高島浩明（愛知医科大学循環器内科）

PJ105-1 Mechanical Stress and Strain of Coronary Plaque Assessed by Speckle-tracking on High-

definition Intravascular Ultrasound (60MHz-ST-IVUS)

田中新一郎（朝日大学病院循環器内科）PJ105-2 Optical Coherence Tomography Findings of Stable Angina Pectoris Lesions with Poor

Coronary Flow Compared with Acute Coronary Syndrome Lesions

木村茂樹（亀田総合病院循環器内科）PJ105-3 Clinical Characteristics of Calcified Nodule within Stent Causing In-stent Restenosis

五十殿弘二（京都第二赤十字病院循環器内科）PJ105-4 Assessment of the Differences of Plaque Characterizations between Coronary Angioscopy and

Optical Coherence Tomography Examination

木村茂樹（亀田総合病院循環器内科）PJ105-5 Prognostic Impact of Calcified Nodule in Patients with End-Stage Renal Disease: An Optical

Coherence Tomography Study

岡村昭彦（奈良県立医科大学循環器内科学）PJ105-6 Association of High Lipoprotein (a) with the Severity of Aortic Atherosclerosis (From Aortic

Angioscopy Study)

臺和興（広島市立病院機構広島市立広島市民病院循環器内科）PJ105-7 Predictors of Restenosis after Non-stenting Coronary Intervention with Drug-coated Balloon

Assessed by Optical Coherence Tomography

中瞬（東京医科歯科大学循環制御内科学）

ポスターセッション（日本語）106 (CAD)3月 31日（日） 14：50－15：40展示ホールIntravascular Imagings 4

座長：西岡利彦（埼玉医科大学総合医療センター心臓内科）山﨑正雄（NTT東日本関東病院循環器内科）

PJ106-1 Relationship between the Presence of Lipid Detected by Near-infrared Spectroscopy and

Stenosis Severity in Terms of Anatomy and Function

羽田昌浩（土浦協同病院循環器内科）PJ106-2 Impact of Optical Coherence Tomography-guided Percutaneous Coronary Intervention on

Clinical Outcomes in Comparison between Patients with and without Diabetes Mellitus

黒田優（明石医療センター循環器内科）PJ106-3 Characteristics of Optical Coherence Tomography Finding Relating to Stent Thrombosis after

Index PCI

経堂篤史（奈良県立医科大学循環器内科）PJ106-4 Association between Achilles Tendon Thickness and Coronary Plaque Vulnerability in 3

Coronary Major Branches in Patients with Acute Coronary Syndrome

江渕康柔（日本大学循環器内科）PJ106-5 Microluminal Structures of Coronary Plaque and Vasa Vasorums Affect Coronary

Inflammation: A Fresh Cadaveric Study

伊藤浩敬（徳島大学循環器内科）PJ106-6 The Extent of Lipidic Components Associates with Thrombogenecity at Culprit Plaque in ACS:

Insight from OCT and NIRS Imaging Analysis

北原慧（国立循環器病研究センター心臓血管内科）PJ106-7 Neointimal Characteristics by Optical Coherence Tomography in Coronary In-stent Restenosis

Lesions with Internal Running Neointimal Microvessels

天野英夫（東邦大学内科学講座循環器内科学分野）

March

31

PM

446

ポスターセッション（日本語）107 (CAD)3月 31日（日） 14：50－15：40展示ホールThromboembolism 1

座長：村﨑かがり（東京女子医科大学循環器内科学・予防医学科）海北幸一（熊本大学生命科学研究部循環器内科学）

PJ107-1 Design and Baseline Characteristics of the Edoxaban Real-world Observational Study in

Japanese Patients with Venous Thromboembolism (ETNA-VTE-Japan)

山田典一（桑名市総合医療センター）PJ107-2 Risk Factors for Intestinal Bleeding in Patients Receiving Antithrombotic Therapy in the Era of

Helicobacter Pylori Eradication Therapy

山野貴司（和歌山県立医科大学循環器内科学）PJ107-3 Long-term Outcomes of Patients with Pulmonary Embolism versus Deep Vein Thrombosis:

From the COMMAND VTE Registry

村田耕一郎（静岡市立静岡病院循環器内科）PJ107-4 Comparison of Edoxaban Plasma Concentration Determined by Direct and Indirect Methods in

Patients with Non-valvular Atrial Fibrillation (CVI ARO 7)

鈴木信也（心臓血管研究所循環器科）PJ107-5 Comparison of Efficacy and Safety of Direct Oral Anticoagulants with Warfarin in Asian

Patients with Post-operative Fresh Venous Thromboembolism

下髙原淳一（米盛病院救急科・循環器科）PJ107-6 Dilatation of the Popliteal Vein is the Risk Factor for Pulmonary Thrombus in Patients with

Venous Thromboembolism

山田崇史（JA愛知厚生連海南病院循環器内科）PJ107-7 Pharmacokinetics Analysis of Apixaban in Patients with NVAF below and above 75 Years Old

菅原里恵（獨協医科大学循環器・腎臓内科）


座長：大嶋秀一（熊本中央病院循環器科）河合勇介（岡山市立市民病院循環器内科）

PJ108-1 Estimation of Plasma Concentration of Edoxaban by Anticoagulation Markers in Japanese

Patients with Non-valvular Atrial Fibrillation (CVI ARO 7)

鈴木信也（心臓血管研究所循環器科）PJ108-2 Novel Quantitative Evaluation Method of Thrombus Volume by Ultrasound in Patients with

Lower Limb Deep Vein Thrombosis: Correlation with Computed Tomography

久武真二（東邦大学内科学講座循環器内科学分野）PJ108-3 Use of Anticoagulation and Incidence of Thrombotic and Bleeding Events in Patients

Undergoing Percutaneous Coronary Intervention (PCI): Shinken Database Analysis

新井陸（心臓血管研究所循環器内科）PJ108-4 The Characteristics and Clinical Outcomes of the Japanese AF Patients with High HAS-BLED

Score: The Fushimi AF Registry

池田周平（京都医療センター循環器内科）PJ108-5 Body Mass Index and Blood Pressure are Independently Associated with Higher Levels of D-

dimer in Anticoagulated Patients with Atrial Fibrillation

岡村昌宏（鳥取大学病態情報内科学）PJ108-6 Association between Changes in Platelet Reactivity during Elective Percutaneous Coronary

Intervention with Prasugrel Pretreatment and Periprocedural Myocardial Infarction

河合勇介（岡山市立市民病院循環器内科）PJ108-7 Blood Coagulation Status after Transcatheter Aortic Valve Implantation in Patients with Atrial

Fibrillation

片山大河（帝京大学循環器内科）

March

31

PM

447


座長：堀内久徳（東北大学加齢医学研究所加齢制御研究部門基礎加齢研究分野）梅谷健（山梨県立中央病院循環器内科）

PJ109-1 Clinically Feasible Novel Method for Assessing Leukocyte Rheological Activation in Whole

Blood in ex Vivo安隆則（獨協医科大学日光医療センター心臓・血管・腎臓内科）

PJ109-2 Distribution on Anti-factor Xa Activity Depending on the Body Weight in Patients on Edoxaban

Therapy

小野亮平（松戸市立総合医療センター循環器内科）PJ109-3 Total Thrombus-formation Analysis System Detects Low Thrombogenicity in Coronary Artery

Disease Patients with Renal Dysfunction

中西信博（熊本大学循環器病態学）PJ109-4 Edoxaban Eliminates Hypercoagulability Evoked by Transient Temperature Change

鈴木杏奈（東京医科歯科大学循環生理解析学）PJ109-5 Another Type of Venous Thromboembolism (VTE): Portal Vein Thrombosis (PVT)’s Current

Situation

金史彦（聖隷三方原病院循環器科）PJ109-6 Effectiveness of Direct Oral Anticoagulants to Reduce Thrombus Size in Patients with Venous

Thromboembolism Compared with Warfarin

千田啓介（信州大学循環器内科学）PJ109-7 The Characteristics of the Elder Patients with Acute Pulmonary Embolism: From the Tokyo

CCU Network Registry Database

正司真（東京都CCUネットワーク学術委員会）

ポスターセッション（日本語）110 (A)3月 31日（日） 14：50－15：40展示ホールNewMapping Technology

座長：宮永哲（東京慈恵会医科大学柏病院循環器内科）田中耕史（桜橋渡辺病院心臓血管センター不整脈科）

PJ110-1 Superior Vena Cava Mapping and Electrical Isolation Using a Novel Ultra-high Resolution 3-

dimensional Mapping System

向井萌（福井大学循環器内科）PJ110-2 The Feature of High-density Mapping Systems: The Direct Comparison between RHYTHMIA

with ORION and EnSite with HD Grid

田中泰章（横須賀共済病院循環器センター内科）PJ110-3 Catheter Ablation for Manifest Wolff-Parkinson-White Syndrome Using Ultra-high-resolution

Three-dimensional Mapping System: A Potential Benefit to Identify Complex Accessory

Pathway

柳澤哲（名古屋大学先進循環器治療学講座）PJ110-4 Insights with High-resolution Mapping of Electrophysiological Breakthroughs from the Left

Atrium to Pulmonary Veins

山下省吾（東京慈恵会医科大学循環器内科）PJ110-5 High-resolution Mapping of the Accessory Pathways

後藤貢士（埼玉医科大学国際医療センター心臓内科）PJ110-6 Automatic High Density Mapping Facilitates Identification of the Critical Channel in the

Tachycardia Circuit of Uncommon Atrial Flutter

古山准二郎（済生会熊本病院心臓血管センター循環器内科）PJ110-7 A Repeat Atrial Fibrillation Ablation Using an Ultra-high-resolution Mapping System

増田正晴（関西労災病院心臓血管センター）

March

31

PM

448

ポスターセッション（日本語）111 (A)3月 31日（日） 14：50－15：40展示ホールPacemaker

座長：山田忠克（愛媛県立中央病院循環器内科）新田正光（千葉西総合病院循環器科）

PJ111-1 Impact of Admission Heart Rate and Systolic Blood Pressure on Pacemaker Dependency in

Patients with Complete Atrioventricular Block

片岡翔平（東京都CCUネットワーク学術委員会）PJ111-2 Utility of New Catheter Delivery System on Ventricular Lead Implantation: Comparison with

Standard Stylet Delivery System

山形研一郎（国立循環器病研究センター）PJ111-3 Usefulness of Lead Delivery Catheter System for “true” Right Ventricular Septal Pacing

岡崎絢子（聖隷三方原病院循環器科）PJ111-4 The Association between Specialty of Electrophysiology and Severe Complication Rate of

Pacemaker Implantation

上松弘幸（関西労災病院循環器内科）PJ111-5 Successful Treatment of Anti-tachycardia Pacing: The Impact of Characteristics of Tachycardia

and Pacing on Arrhythmia Termination

岡島英梨（東京慈恵会医科大学循環器内科）PJ111-6 The Correlation between Duration of Delta Wave and Left Ventricular Mechanical

Dyssynchrony in Non-selective His Bundle Pacing

須賀一将（JCHO中京病院循環器内科）PJ111-7 Usefulness of Contrast Media Injection at Tip of the Right Ventricular Lead to Detect Lead

Perforation Compared to Computed Tomography

佃早央莉（岡山大学循環器内科学）

ポスターセッション（日本語）112 (A)3月 31日（日） 14：50－15：46展示ホールAnticoagulation

座長：原田智雄（聖マリアンナ医科大学循環器内科）伴場主一（心臓病センター榊原病院循環器内科）

PJ112-1 How Frailty Influences on Bleeding Events Regarding Anticoagulant Therapy in Patients with

Heart Failure and Atrial Fibrillation

太田真之（手稲渓仁会病院心臓血管センター循環器内科）PJ112-2 Impact of Cancer on Bleeding and Ischemic Stroke in Atrial Fibrillation Patients Taking

Rivaroxaban: A Direct Oral Anticoagulant

秋津克哉（東邦大学内科学講座循環器内科学分野）PJ112-3 A Novel Simple Risk Score for the Prediction of Bleeding in Atrial Fibrillation Patients with

Direct Oral Anticoaglants

川崎真佐登（大阪急性期・総合医療センター心臓内科）PJ112-4 The Impact of Renal Function on the Clinical Events in Atrial Fibrillation Patients with DOAC

佐藤貴雄（立川綜合病院）PJ112-5 The Impact of Frailty on Major Bleeding and Stroke in Patients Using Direct Oral

Anticoagulants

佐藤貴雄（立川綜合病院）PJ112-6 Selective under Dose of DAOC may be Reasonable Option for Stroke Prevention in Non-valvar

Atrial Fibrillation Patients

宮村昌利（大阪医科大学内科学Ⅲ）PJ112-7 DOAC Decreases Mortality after Bleeding/Thromboembolic Events in Patients with Atrial

Fibrillation

野々村誠（済生会富山病院内科）PJ112-8 Risk of Ischemic Stroke and Need for Oral Anticoagulation after Catheter Ablation of Atrial

Fibrillation

遠山英子（福岡山王病院ハートリズムセンター）

March

31

PM

449

ポスターセッション（日本語）113 (A)3月 31日（日） 14：50－15：40展示ホールArrhythmia, Basic

座長：吉岡公一郎（東海大学内科学系循環器内科学）中野由紀子（広島大学循環器内科）

PJ113-1 Algorithmic Auto-recreation System of hiPSC-CMs Simulation and Prediction of Drug Testing

糀谷泰彦（京都大学循環器内科）PJ113-2 Intolerance to Rapid Ventricular Pacing and Coronary Hypoplasty in Pannexin-1 Knockout

Mouse Heart

井原健介（東京医科歯科大学難治疾患研究所生体情報薬理学分野）PJ113-3 Slow Pacemaking by Attenuated Beta-adrenergic Response in Tric-a Knockout Mice

外山佑一（弘前大学循環器腎臓内科学講座）PJ113-4 A Lesion Created by Repeated Applications at the Same Site Distorts the Ablation Index-based

Lesion Size

大塚直人（日本大学循環器内科）PJ113-5 Chronically Administered Fingolimod Provides a Novel Therapeutic Strategy for Atrial

Fibrillation Assessed in the Rat Hypertrophy Model with Aorto-venocaval Shunt

相本恵美（東邦大学薬学部薬物治療学）PJ113-6 Interleukin-6 Mediates Arrhythmogenic Atrial Remodeling in Mice

山上文（筑波大学循環器内科学）PJ113-7 The Correlation between Circulating Intermediate CD14++CD16+Monocytes and Atrial

Electrical Remodeling in Atrial Fibrillation Patients

末廣英也（神戸大学循環器内科）

ポスターセッション（日本語）114 (A)3月 31日（日） 14：50－15：40展示ホールAtrial Tachycardia

座長：清水宏紀（六甲アイランド甲南病院循環器内科）井川昌幸（筑波記念病院循環器内科）

PJ114-1 Macroreentrant Atrial Tachycardia Originating from Left Atrial Anterior Wall after

Radiofrequency Pulmonary Venous Isolation for Long-standing Persistent Atrial Fibrillation

大西克実（昭和大学内科学講座循環器内科学部門）PJ114-2 Atrial Tachyarrhythmia Recurrence after Ablation for Atrial Fibrillation in Patients with Low

Voltage Zone in the Left Atrium

岡松秀治（済生会熊本病院心臓血管センター循環器内科）PJ114-3 Atrial Tachycardia Occurring after Surgical Maze Procedure or Stepwise Catheter Ablation

中島淳（横須賀共済病院循環器センター内科）PJ114-4 Prevalence and Reentrant Circuit Features of Biatrial Tachycardia

北村健（Department of Electrophysiology, LIRYC, Bordeaux University, CHU de Bordeaux, France）PJ114-5 Ultrahigh Resolution Mapping System Optimizes Catheter Ablation of Atrial Tachycardia

石川恵理（福井大学循環器内科）PJ114-6 Clinical and Electrophysiological Characteristics of Atrial Tachycardia after Open Heart Surgery

of Non-congenital Heart Disease

井上義明（松江赤十字病院循環器内科）

March

31

PM

450

ポスターセッション（日本語）115 (HF/CM)3月 31日（日） 14：50－15：40展示ホールHeart Failure (Laboratory/Biomarkers)

座長：山田貴久（大阪急性期・総合医療センター心臓内科）衣笠良治（鳥取大学循環器内科）

PJ115-1 Prognostic Value of a New Systemic Nutrition-inflammation Index in Acute Decompensated

Heart Failure: A Comparison with Neutrophil to Lymphocyte Ratio

山田貴久（大阪急性期・総合医療センター）PJ115-2 Prognostic Value of Fibrosis-4 Index in Acute Decompensated Heart Failure: A Prospective

Comparative Study with Other Liver Fibrosis Score

川平正継（大阪急性期・総合医療センター心臓内科）PJ115-3 Clinical Significance of SerumMagnesium Levels in Patients with Heart Failure with Preserved

Ejection Fraction

西原大貴（熊本大学循環器内科学）PJ115-4 C-reactive Protein to Prealbumin Ratio on Admission and Mortality in Patients Hospitalized for

Acute Heart Failure

春木伸太郎（東京女子医科大学循環器内科学）PJ115-5 Comparison of the Prognostic Values of Formulas for the Estimation of Plasma Volume in

Patients Admitted for ADHF

玉置俊介（大阪急性期・総合医療センター心臓内科）PJ115-6 Long-term Prognostic Value of Cardiorenohepatic Syndrome in Patients Admitted for Acute

Decompensated Heart Failure

山田貴久（大阪急性期・総合医療センター）PJ115-7 Ratio of Systolic Function-to-Pressure of Right Ventricule Predicts Mortality in Acute Heart

Failure Patients with Left Ventricular Systolic Dysfunction

亀谷智子（東京女子医科大学循環器内科）

ポスターセッション（日本語）116 (HF/CM)3月 31日（日） 14：50－15：40展示ホールPulmonary Circulation 2

座長：牧尚孝（東京大学循環器内科）足立史郎（名古屋大学肺高血圧先端医療学寄附講座）

PJ116-1 Comparison of Pulmonary Vascular Resistance and Pulmonary Artery Compliance during

Exercise between IPAH and CTEPH with Normal Pulmonary Artery Pressure

合田あゆみ（杏林大学循環器内科）PJ116-2 Clinical Impact of High-sensitive Cardiac Troponin T in the Patients with Chronic

Thromboembolic Pulmonary Hypertension

山方勇樹（長崎大学病院循環器内科）PJ116-3 Perinatal Origin of Pulmonary Arterial Hypertension: From a Newly Established FatalSugen/

Hypoxia Rat Model

大下裕法（三重大学小児科）PJ116-4 Impact of Balloon Pulmonary Angioplasty (BPA) on Renal Function in the Patients with Chronic

Thromboembolic Pulmonary Hypertension

山方勇樹（長崎大学循環器内科）PJ116-5 Effect of Additional Balloon Pulmonary Angioplasty for Residual Pulmonary Hypertension after

Surgical or Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension

兼澤弥咲（岡山医療センター循環器科）PJ116-6 Genetic Deletion of Fatty Acid Synthase in Vascular Smooth Muscle Cell Ameliorates

Monocrotaline-induced PAH in Mice

古川聡子（群馬大学保健学研究科生体情報検査科学講座）PJ116-7 Exercise Pulmonary Hypertension is Related with Right Ventricular Dysfunction and Exercise

Intolerance in CTEPH Patients with Normalized Resting Hemodynamics

合田あゆみ（杏林大学循環器内科）

March

31

PM

451

ポスターセッション（日本語）117 (HF/CM)3月 31日（日） 14：50－15：40展示ホールCardiomyopathy/Hypertrophy Clinical 1

座長：大木元明義（市立宇和島病院循環器内科）加藤貴雄（京都大学循環器内科）

PJ117-1 Efficacy of Screening by 99mTc-labeled Pyrophosphate Scintigraphy for Cardiac Transthyretin

Amyloidosis in Elderly Heart Failure Patients

滝美波（信州上田医療センター循環器内科）PJ117-2 The Change of Longitudinal Strain in Speckle-tracking Echocardiography in Patients after

Domino Liver Transplantation

宇宿弘輝（熊本大学中央検査部）PJ117-3 Clinical Characteristcs and Natural History of Wild Type Transthyretin Cardiac Amyloidosis in

Our Hospital

山田敏寛（熊本大学循環器内科/国立病院機構熊本医療センター心臓血管センター循環器内科）PJ117-4 The Characteristics of Myocardial Strain in Patients with Cardiac Amyloidosis

石黒まや（榊原記念病院循環器内科）PJ117-5 Outcome of the Medical Treatments with Angiotensin-converting Enzyme Inhibitors and Beta

Blockers for Cardiomyopathy in Duchenne Muscular Dystrophy

石黒まや（榊原記念病院循環器内科）PJ117-6 Difference of Characteristic Clinical Features between Males and Females in 18 Cases of Fabry

Disease

馬渡一寿（久留米大学内科心臓・血管内科）PJ117-7 The Prevalence and the Relation to the Cardiac Manifestation of Urinary Mulberry Bodies in

Fabry Disease during Enzyme Replacement Therapy

本郷賢一（東京慈恵会医科大学循環器内科）


座長：河野浩章（長崎大学循環器内科学）坂本央（旭川医科大学循環・呼吸・神経病態内科）

PJ118-1 Associations of Soluble Neprilysin with Cardiac Function and Outcome in Patients with

Hypertrophic Cardiomyopathy

横川哲朗（福島県立医科大学循環器内科）PJ118-2 B-type Natriuretic Peptide and Outcome in Patients with Apical Hypertrophic Cardiomyopathy

城谷翔太（東京女子医科大学循環器内科）PJ118-3 T1/2 as a Predictor of Cardiac Events in Cardiomyopathy with Systolic and/or Diastolic

Dysfunction

横井剛（名古屋大学循環器内科学）PJ118-4 Criteria for Increased Left Ventricular Thickness to Screen Childhood Hypertrophic

Cardiomyopathy (HCM) at a School-based Cardiovascular Screening Program

吉永正夫（国立病院機構鹿児島医療センター小児科）PJ118-5 The Association between Morphology and Myocardial Damage in Apical Hypertrophic

Cardiomyopathy Assessed by Cardiac Magnetic Resonance

伊藤順子（心臓画像クリニック飯田橋循環器科）PJ118-6 Clinicopathological and Genetic Features of Pathologically Proven Hypertrophic

Cardiomyopathy

畑由紀子（富山大学法医学）PJ118-7 Cardiac MRI-derived TAPSE is One of Prognostic Markers in Patients with Hypertrophic

Cardiomyopathy

中村貴（近畿大学循環器内科学）

March

31

PM

452


座長：藤野陽（金沢大学保健学系）髙見澤格（榊原記念病院循環器内科）

PJ119-1 Novel Score to Predict Resolution of Complete or Advanced Atrioventricular Block after

Steroid Therapy in Patients with Cardiac Sarcoidosis

鍋田健（北里大学循環器内科学）PJ119-2 Lower Left Ventricular Ejection Fraction can Independently Predict the Refractoriness to

Immunosuppressive Treatment in Patients with Cardiac Sarcoidosis

大谷規彰（九州大学循環器内科学）PJ119-3 18F-fluoro-2-deoxy-D-glucose Positron Emission Tomography Uptake in the Right Superior

Paratracheal Lymph Node Predicts a Complete Atrioventricular Block in Cardiac Sarcoidosis

松永圭司（香川大学循環器・腎臓・脳卒中内科）PJ119-4 Imaging Characteristic on 18F-FDG-PET/CT and Clinical Feature in Cardiac Sarcoidosis Patients

Complicated by Ventricular Aneurysm

南野巧真（山口大学器官病態内科学）PJ119-5 Impact of Corticosteroid Therapy on Reverse Remodeling in Patients with Cardiac Sarcoidosis

佐藤希美（筑波大学循環器内科）PJ119-6 Ongoing Inflammation: A Significant Predictor of One-year Mortality in Patients with

Takotsubo Syndrome?

小林佑輔（広島市立安佐市民病院循環器内科）PJ119-7 Cardiac Involvement of Patients with Eosinophilic Granulomatosis with Polyangiitis and the

Role of B-type Natriuretic Peptide

中山未奈（国立病院機構相模原病院循環器内科）

ポスターセッション（日本語）120 (HF/CM)3月 31日（日） 14：50－15：40展示ホールTransplantation/LVAD/Infection

座長：布田伸一（東京女子医科大学重症心不全制御学分野）藤野剛雄（シカゴ大学循環器内科）

PJ120-1 Impact of Possible Community-acquired Methicillin-resistant Staphylococcus Aureus in

Patients with Cardiovascular Implantable Electronic Device Infection

福永真人（小倉記念病院循環器内科）PJ120-2 Prediction of Acute Phase Complications in Patients with Infectious Endocarditis

齋藤史哉（獨協医科大学心臓・血管内科）PJ120-3 Optimization of Histocompatibility Tests for the Heart Transplantation in Japan

服部英敏（東京女子医科大学循環器内科学）PJ120-4 FDG-PET Evaluation of Early Cardiac and Lymph Node Response to Prednisolone in Patients

with Cardiac Sarcoidosis

柏村健（新潟大学先進心肺血管治療学）PJ120-5 Prediction of Aortic Regurgitation after Continuous-flow Left Ventricular Assist Device

Implantation Using Artificial Intelligence Trained on Acoustic Spectra

三隅祐輔（大阪大学心臓血管外科）PJ120-6 Jarvik 2000 Left Ventricular Assist Device can Support Left Ventricular Adequately Regardless

of Body Size or Preoperative Cardiac Function

岩花東吾（千葉大学循環器内科学）PJ120-7 Clinical Characteristics for Identifying Candidates for Considering Heart Transplantation

宮脇大（大阪大学循環器内科学）

March

31

PM

453

ポスターセッション（日本語）121 (VD/RF)3月 31日（日） 14：50－15：40展示ホールVascular Biology (Therapy) 1

座長：当麻正直（兵庫県立尼崎総合医療センター循環器内科）丸山秀和（霞ヶ浦医療センター循環器内科）

PJ121-1 Assessment of Complexity about Intraluminal Approach for Occlusive Femoropopliteal

Lesions

本多洋介（済生会横浜市東部病院循環器内科）PJ121-2 Clinical Impact of Activities of Daily Living at Discharge in Rutherford 5 Critical Limb Ischemia

Patients after Endovascular Therapy

阪本泰成（済生会横浜市東部病院循環器内科）PJ121-3 Clinical Results of PTA for 258 Central Venous Lesions with Chronic Hemodialysis Patients

堀田祐紀（心臓血管センター金沢循環器病院循環器内科学）PJ121-4 Intravascular Ultrasound Documents Various Dissection Patterns in Femoro-popliteal Lesions

Receiving Drug-coated Balloons with Angiographically Non-severe Dissection

岩田曜（船橋市立医療センター循環器内科）PJ121-5 One-year Outcomes after Viabahn Stent Grafts for Patients with Peripheral Artery Diseaes

Presenting Femoropopliteal Artery Lesions

辻村卓也（関西労災病院循環器内科）PJ121-6 Lipoprotein(a) is a Useful Biomarker for the Prediction of Prognosis after Endovascular

Therapy for Superficial Femoral Artery

三須彬生（横須賀共済病院循環器センター内科）PJ121-7 2-years Clinical Outcomes Comparing the Drug Eluting Stent and the Second-Generation Bare

Nitinol Stent for de Novo Femoropopliteal Lesions

緒方健二（宮崎市郡医師会病院心臓病センター循環器科）

ポスターセッション（日本語）122 (VD/RF)3月 31日（日） 14：50－15：40展示ホールVascular Biology (Therapy) 2

座長：上杉道伯（うえすぎクリニック）木下愼（神戸市立医療センター中央市民病院循環器内科）

PJ122-1 Impact of Full-cover Stenting in Femoropopliteal Lesions on Time to Wound Healing in

Patients with Critical Limb Ischemia

島田健晋（倉敷中央病院循環器内科）PJ122-2 Consideration of VIABAHN Stent Graft Thrombosis from the Viewpoint of Angiography, IVUS

and Pathology

栗本真吾（徳島赤十字病院循環器内科）PJ122-3 Efficacy and Safety of Transcatheter Treatment for Frozen Shoulder Resistant to Conservative

Treatment

岩破俊博（丸太町病院心臓内科）PJ122-4 Prognostic Impact of Nutritional Indexes on Outcomes in Patients with Critical Limb Ischemia

after Endovascular Treatment

布施大望（河北総合病院循環器内科）PJ122-5 Malnutrition and Non-use Clopidogrel Additively Aggravate Prognosis of Critical Limb

Ischemia Patients who Underwent Revascularization

神田大輔（鹿児島大学心臓血管・高血圧内科学）PJ122-6 Long-term Prognostic Value of Preoperative Anemia Depends on the Severity of Renal

Function in Patients with Peripheral Artery Disease

溝渕景子（東京女子医科大学循環器内科学）PJ122-7 Outcomes of Endovascular Treatment for Patients with Scleroderma

山上将央（森之宮病院循環器内科）

March

31

PM

454

ポスターセッション（日本語）123 (VD/RF)3月 31日（日） 14：50－15：40展示ホールVascular Biology

座長：得能智武（九州大学別府病院内科）上田和孝（東京大学循環器内科）

PJ123-1 Endothelial Adrenomedullin-RAMP2 System Regulates Vascular Integrity and Suppresses

Tumor Metastasis

田中愛（信州大学循環病態学教室）PJ123-2 Cyanoacrylate Embolization for Great Saphenous Vein Reflux in Real World: The First Mid-

term Result in Japan

榊原直樹（江戸川病院心臓血管外科）PJ123-3 Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Major Bleeding

after Endovascular Therapy

菱刈景一（横須賀共済病院循環器センター内科）PJ123-4 Outcomes and Risk Factor of Medically Treated Acute Stanford Type A Aortic Dissection with

Non-communicating False Lumen

三竹啓嗣（静岡市立静岡病院循環器内科）PJ123-5 Factors Associated with 30-day Mortality after Endovascular Therapy in the Patients with

Critical Limb Ischemia

浮田康平（大阪労災病院循環器内科）PJ123-6 Androgen, but not Estrogen, Contributes to Sex Difference in Aortic Aneurysm Formation in

Marfan Syndrome

柳青（東京大学循環器内科）PJ123-7 Ultrastructural Alteration of Endothelial Glycocalyx in Chronic Kidney Disease-associated

Heart Failure

岡田英志（岐阜大学高次救命治療センター）

ポスターセッション（日本語）124 (SHD)3月 31日（日） 14：50－15：40展示ホールValvular Heart Disease

座長：舟田晃（金沢大学救急部）池永寛樹（広島大学循環器内科）

PJ124-1 Various Aortic Valve Disease and Mitral Regurgitation also Affect Time Phase Changes of

Aortic Valve Annulus Morphology within Cardiac Cycle

小松博史（NTT東日本札幌病院循環器内科）PJ124-2 Prognostic Value of Changes in Global Longitudinal Strain after TAVI in Patients with

Preserved Left Ventricular Ejection Fraction

坂口英林（藤田医科大学循環器内科学）PJ124-3 Home Discharge after Transcatheter Aortic Valve Implantation

武藤雄紀（榊原記念病院循環器内科）PJ124-4 Mid-term Mortality in Patients after Undergoing Transcatheter Aortic Valve Replacement

(TAVR) Stratified by Preoperative Risk Score: Multicenter TAVR Registy

齋藤悠司（山形大学循環・呼吸・腎臓内科学）PJ124-5 Heart-type Fatty Acid-binding Protein Predicts Improvement of Left Ventricular Function after

Transcatheter Aortic Valve Implantation in Aortic Valve Stenosis Patients

橋本直土（山形大学内科学第一講座）PJ124-6 Risk Factors for Recurrent Mitral Regurgitation after Mitral Valve Repair for Atrial Functional

MR

辛島千尋（別府医療センター）PJ124-7 Presence of Left Ventricular Diastolic Dysfunction Disturbs Acute Cardiac Unloading after

Transcatheter Aortic Valve Implantation

土屋隼人（山形大学循環・呼吸・腎臓内科学）

March

31

PM

455

ポスターセッション（日本語）125 (IMG)3月 31日（日） 14：50－15：40展示ホールCT MRI New Technology

座長：船橋伸禎（千葉大学循環器内科学）阿部弘太郎（九州大学循環器内科）

PJ125-1 Utilizing Fractional Flow Reserve Derived from CT Angiography to Optimize Evaluation in

Stable CAD and the Relationship to Midterm Outcome

小此木太一（新古賀病院心臓血管センター）PJ125-2 Association of Atrial Fibrillation and MRI-derived Coronary Flow Reserve in Patients with Heart

Failure

杉本洋一郎（イムス三芳総合病院循環器内科）PJ125-3 An Automatic Quantitative Method for Measuring Epicardial Adipose Tissue in Coronary

Computed Tomography Angiography Using Deep Convolutional Neural Networks

手塚祐司（草津総合病院糖尿病内分泌内科）PJ125-4 A Novel Clinical Method for Quantification of Stroke Work by Left Ventricular Pressure-volume

Loop Area Constructed by 3-dimensional Echocardiography

吉眞孝（岐阜県総合医療センター循環器内科）PJ125-5 Sub-mSv Coronary Computed Tomography Angiography Using Dual Source Computed

Tomography

小松誠（大阪暁明館病院心臓血管病センター）PJ125-6 Difference in Functional Focal and Diffuse Coronary Artery Disease of Fractional Flow Reserve

from Coronary Computed Tomography Angiography

石川有（岩手医科大学循環器内科）PJ125-7 Evaluation Method of Pulmonary Perfusion by Sequential Radiography: Preliminary Study in

Monkey

宮武秀光（滋賀医科大学集中治療）

ポスターセッション（日本語）126 (O)3月 31日（日） 14：50－15：40展示ホールBasic Research 2

座長：安武正弘（日本医科大学総合医療・健康科学分野）長谷川洋（ANA成田グループ健康管理室）

PJ126-1 Glucagon-like Peptide 1 Analogue Regulates Mitochondrial Fusion Proteins via Akt

Phosphorylation and Attenuates Hypoxia-reoxygenation Injury in Cultured Myocytes

小原幸（京都薬科大学臨床薬理学）PJ126-2 Antidiabetic Agent Metformin Suppressed Cardiomyocyte Hypertrophy and p300 HAT Activity

清水圭貴（静岡県立大学薬学研究院分子病態学講座）PJ126-3 Role of Cardiac Steroidogenic Acute Regulatory Protein in Pulmonary Arterial Hypertension: A

Novel Treatment with Mineralocorticoid Receptor Antagonists and Anticoagulant

山本ゆい（大阪薬科大学循環病態治療学研究室）PJ126-4 A Novel Senolytic Drug for Aging and Age-related Cardiometabolic Disorders

勝海悟郎（新潟大学循環器内科）PJ126-5 Angiotensin Receptor Neprilysin Inhibitor Attenuates Abdominal Aortic Aneurysm in

Angiotensin II Infused Mice

田代浩平（福岡大学心臓血管内科学）PJ126-6 Direct Injection of Vascular Cell Adhesion Molecule-1-positive Cardiac Fibroblasts Improves

Cardiac Dysfunction after Myocardial Infarction

村越伸行（筑波大学循環器内科）

March

31

PM

456

ポスターセッション（日本語）127 (O)3月 31日（日） 14：50－15：40展示ホールPharmacotherapy/Cost-health Care System

座長：八島正明（日本医科大学内科学（循環器内科学））岩田幸代（兵庫県立加古川医療センター循環器内科）

PJ127-1 Serious Major Complications of Spasm Provocation Testing in 2500 Patients

末田章三（愛媛県立新居浜病院循環器内科）PJ127-2 Safety of Uninterrupted Periprocedural Low Dose Dabigatran in Patients Undergoing

Radiofrequency Catheter Ablation of Atrial Fibrillation

大坂友希（青梅市立総合病院循環器内科）PJ127-3 Platelet Inhibition with Ticagrelor 60 mg Twice Daily versus Prasugrel 3.75mg Once Daily in

Japanese Patients

立石和也（千葉大学循環器内科）PJ127-4 The Relationship between Proton Pump Inhibitor and Platelet Aggregation in Patients with

Prasugrel

諸國元太郎（岡山市立市民病院循環器内科）PJ127-5 Dose Maximal Acetylcholine Dose into the Left Coronary Artery Affect the Positive Provoked

Spasm in the Left Circumflex Artery?

末田章三（愛媛県立新居浜病院循環器内科）PJ127-6 The Association between Increased Blood Pressure and Excessive Medical Expenses in Middle-

aged Male Workers

西城由之（日本医科大学循環器内科）

March

31

PM

457

日本循環器学会委員会セッション（医療安全部会）3月 31日（日） 13：00－14：00国立大ホール 2階医療安全に関する講演会座長：三浦哲嗣（札幌医科大学循環器・腎臓・代謝内分泌内科学講座）

「医療事故調査制度」と医療安全木村壮介（日本医療安全調査機構）

日本循環器学会委員会セッション（倫理委員会）3月 31日（日） 14：00－15：00国立大ホール 2階倫理に関する講演会座長：瀧原圭子（大阪大学キャンパスライフ健康支援センター）

研究倫理における被験者保護とサイエンスジェンナーから臨床研究法まで植田真一郎（琉球大学臨床薬理学講座）

日本循環器学会委員会セッション（学術委員会）3月 31日（日） 13：30－15：00会議センター 3階「315」2017年度メディカルスタッフ（医師を除く医療専門職）研究助成報告会座長：大手信之（名古屋市立大学心臓・腎高血圧内科学）

1．磁気共鳴画像を用いた心筋虚血再灌流傷害の非侵襲的診断法の確立河窪正照（九州大学医用量子線科学分野）

2．心不全で入院したフレイルな高齢者の機能予後並びに生命予後を改善するための循環器予防研究田中伸弥（名古屋大学リハビリテーション部）

3．心不全における骨格筋繊維化の臨床的意義と機序の解明角谷尚哉（北海道大学循環病態内科学）

March

31

PM

458

チーム医療セッションシンポジウム 4 (O)3月 31日（日） 13：30－15：00会議センター 3階「304」【日本心血管理学療法学会-日本循環器学会ジョイントシンポジウム】重複障害を有する超高齢心疾患患者に対するリハビリテーションの工夫～難渋重症例をどのように対応するか？～座長：渡辺敏（聖マリアンナ医科大学）高橋哲也（順天堂大学保健医療学部開設準備室/順天堂大学リハビリテーション室）

1．後期高齢心不全患者に対する急性期離床プログラムの開発と運用角谷尚哉（北海道大学循環病態内科学）

2．重複障害を有する大血管疾患症例における多職種連携とリハビリテーションの工夫宮澤僚（昭和大学藤が丘リハビリテーション病院リハビリテーションセンター）

3．低侵襲治療を補完する在宅心臓リハビリテーションの可能性緒方光（訪問看護ステーションレシーブ）

4．心不全患者の低栄養状態を嚥下障害から考える横田純一（東北大学内部障害学分野）

5．低栄養状態にある後期高齢心不全患者に対する理学療法の工夫片野唆敏（札幌医科大学リハビリテーション部）

チーム医療セッションシンポジウム 5 (IMG)3月 31日（日） 15：10－16：40会議センター 3階「304」【日本放射線技術学会-日本循環器学会ジョイントシンポジウム】インターベンション治療における新しい画像支援技術座長：小林欣夫（千葉大学循環器内科学）坂本肇（山梨大学放射線部）

1．医師が放射線技師に求める画像支援：PCI、SHD intervention長沼亨（新東京病院心臓内科）

2．医師が放射線技師に求める画像支援―カテーテルアブレーション―近藤祐介（千葉大学不整脈先端治療学）

3．心臓MRI検査における新たな高速撮像技術吉田学誉（東京警察病院放射線科）

4．インターベンション領域における心臓超音波検査の実際と役割堀貴好（大垣市民病院診療検査科）

5．CTでの循環器領域における 3D画像支援坂倉徳哉（名古屋ハートセンター放射線部）

チーム医療セッション一般演題（ポスター）28 (O)3月 31日（日） 14：50－15：40展示ホール薬剤 2座長：志賀剛（東京女子医科大学循環器内科）

CP28-1 薬剤師による入院・外来患者を含めたジゴキシン、ピルシカイニドの薬物血中濃度測定結果管理プログラムの成果と今後の展望高橋豊（カレスサッポロ北光記念病院）

CP28-2 服薬アドヒアランスに影響を及ぼす外来患者の意識調査並びに阻害要因の検索大津友紀（福岡大学実務薬剤学）

CP28-3 エボロクマブ在宅自己注射導入チームの構築と患者追跡調査によるアドヒアランス要因の解析安泰成（横須賀共済病院薬剤科）

CP28-4 当院外来の心不全患者に対するトルバプタン長期投与の使用実態調査川崎洸（青梅市立総合病院薬剤部）

CP28-5 末期心不全患者における呼吸困難緩和に対するモルヒネ製剤の使用実態調査國東佑美（兵庫県立尼崎総合医療センター）

March

31

PM

459

CP28-6 慢性心不全患者への睡眠導入薬が睡眠の質に及ぼす影響藤山美里（鳥取大学耳鼻咽喉科）

CP28-7 糖尿病内科と循環器内科の比較による SGLT2阻害薬の治療実態調査大橋泰裕（草津総合病院薬剤部）

チーム医療セッション一般演題（ポスター）29 (A)3月 31日（日） 14：50－15：40展示ホールアブレーション座長：安喰恒輔（JR東京病院循環器内科）

CP29-1 肺静脈隔離における FTIと LSIの有用性についての比較安田奈央（名古屋掖済会病院臨床工学部）

CP29-2 クライオアブレーションにおいて圧力波形解析を用いた肺静脈閉塞の評価阿部祥子（東京山手メディカルセンター臨床工学部）

CP29-3 3タイプのバルーンアブレーションによる肺静脈隔離面積の比較高岡循子（神戸医療センター中央市民病院臨床工学技術部）

CP29-4 Ablation Indexガイドアブレーションの肺静脈隔離術への効果検討中農陽介（神戸市立医療センター中央市民病院臨床工学技術部）

CP29-5 当院における閉塞性睡眠時無呼吸症候群を合併した心房細動アブレーション患者の CPAP導入状況金子紗江佳（桜橋渡辺病院検査科）

CP29-6 発作性心房細動アブレーション患者における閉塞性睡眠時無呼吸症候群の簡易スクリーニング検査の結果濵田紗希（桜橋渡辺病院検査科）

CP29-7 心房細動アブレーション患者における簡易検査機器と終夜睡眠ポリグラフとの無呼吸低呼吸指数の比較諸石武史（桜橋渡辺病院検査科）

チーム医療セッション一般演題（ポスター）30 (O)3月 31日（日） 14：50－15：40展示ホール栄養座長：福尾惠介（武庫川女子大学栄養科学研究所）

CP30-1 食事調査における栄養評価の質的向上に関する検討―食事画像使用時の再現性森山大介（中部ろうさい病院栄養管理）

CP30-2 経カテーテル大動脈弁留置術（TAVI）前後の栄養状態と QOLの関連性大塚俊明（宮崎市郡医師会病院）

CP30-3 TAVI（TA）患者における摂取たんぱく質量による栄養状態とリハビリテーションの関連太田由莉恵（近森病院）

CP30-4 心疾患患者に対する行動変容ステージに応じた栄養指導の長期的効果と血圧への影響要因についての検討松崎景子（福岡大学西新病院栄養管理科）

CP30-5 食事量の変化からみた心不全患者の入院経過について―管理栄養士のかかわり方について考える―本條茉莉（淀川キリスト教病院栄養管理課）

CP30-6 CRT植込み入院患者の栄養指標と食事摂取量の関連浦出華（京都府立医科大学医療技術部栄養課）

CP30-7 心腎連関末期腎不全患者における透析前後の血清ビタミンとビタミン補給飲料の有用性中川明彦（金沢医科大学）

March

31

PM

460

チーム医療セッション一般演題（ポスター）313月 31日（日） 14：50－15：40展示ホール症例報告座長：神吉秀明（さいたま市立病院循環器科）

CP31-1 両心房の側壁に副伝導路が認められた症例に対し、左右異なるマッピング法を実施した 1例杉本寛之（東北大学病院診療技術部臨床工学部門）

CP31-2 Differential Pacingでの治療確認が困難であった通常型心房粗動に対し Rhythmiaによる高密度Mappingが奏功した一例木下黎（東北大学診療技術部臨床工学部門）

CP31-3 洞不全症候群で発症し、成人期～老年期まで心不全症状を呈さない左室緻密化障害の親子例齋藤寛美（わたり病院臨床検査科）

CP31-4 僧帽弁狭窄症を契機に発見された診断に苦慮した三心房心の一例今村華奈子（熊本大学中央検査部）

CP31-5 経時的な観察が可能であった特発性肺動脈拡張症の一例﨑田充（熊本大学中央検査部）

CP31-6 術前の神経筋電気刺激療法を併用した理学療法が有効であった植込型補助人工心臓装着術症例服部慶子（名古屋大学リハビリテーション部）

CP31-7 運動器痛を有する肥満高血圧患者への減量入院で運動療法が有効であった症例佐藤友則（東北労災病院治療就労両立支援センター）

チーム医療セッション一般演題（ポスター）323月 31日（日） 14：50－15：40展示ホールその他座長：菅野康夫（けいゆう病院循環器内科）

CP32-1 人工心肺中の酸素供給量が心臓血管外科術後急性腎不全に与える影響の検討長嶋耕平（東京ベイ・浦安市川医療センター臨床工学室）

CP32-2 心拍出量測定に用いる酸素消費量の新たな推定式の提案宮本聡史（広島大学診療支援部臨床工学部門）

CP32-3 3Dロードマップを使用したクライオアブレーションの工夫大野敦（東京医科大学八王子医療センター）

CP32-4 SAPIEN3の拡張後の高さとバルーン拡張圧および大動脈弁輪面積の関係高橋智子（小倉記念病院）

CP32-5 高感度トロポニン I陽性患者における胸部症状の重要性の検討木下朋幸（横浜市立みなと赤十字病院臨床検査部）

CP32-6 右鎖骨下動脈送血による補助循環下において TAVIを行った 1症例岩田湧斗（聖マリアンナ医科大学クリニカルエンジニア部）

CP32-7 ラット下大静脈絞扼術による下半身うっ血負荷が心肺に与える影響および hemodynamicpreconditioningの効果検証―フォンタン循環への応用にむけて―逢坂大樹（岡山大学心臓血管外科）